syndrome	score	normalized_score
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.220147092	100.0
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.20194415400000001	91.73146561481722
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.20054555400000001	91.09616310534777
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	90.84834970247984
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.2	90.84834970247984
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.069873	31.739233693806867
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.059415004	26.988775304831194
ROTHMUND-THOMSON SYNDROME	0.054742104	24.866149038207602
ACROMELIC FRONTONASAL DYSPLASIA	0.054742104	24.866149038207602
NAIL-PATELLA SYNDROME	0.05419655	24.61833563533967
9Q33.3Q34.11 MICRODELETION SYNDROME	0.0540302	24.54277252047463
PRIMARY PULMONARY HYPOPLASIA	0.0540302	24.54277252047463
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.0540302	24.54277252047463
SCHOLTE SYNDROME; SHLTS	0.053593138	24.344240713386302
SAY-BARBER-MILLER SYNDROME	0.053177154	24.15528341387312
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.053177154	24.15528341387312
PATELLA APLASIA-HYPOPLASIA	0.0526316	23.907470011005188
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.0526316	23.907470011005188
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.0526316	23.907470011005188
17Q23.1Q23.2 MICRODELETION SYNDROME	0.0526316	23.907470011005188
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES	0.0526316	23.907470011005188
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.0526316	23.907470011005188
FRANK-TER HAAR SYNDROME; FTHS	0.04356624	19.789605033710824
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.03957115	17.974868366646422
SECKEL SYNDROME 2; SCKL2	0.036982940000000006	16.799195330729148
CHROMOSOME 9P DELETION SYNDROME	0.036238992000000005	16.461263090406845
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.035818234000000004	16.270137240786266
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.035277454	16.02449238802573
TETRASOMY 5P	0.035277454	16.02449238802573
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.034898250000000006	15.852242100022837
NEONATAL MARFAN SYNDROME	0.0347319	15.7766789851578
TRISOMY 8P	0.034294838	15.578147178069472
STUVE-WIEDEMANN SYNDROME	0.033345478	15.146908231701739
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.0333333	15.141376475688356
CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	0.0333333	15.141376475688356
IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION	0.0333333	15.141376475688356
CONGENITAL TRICUSPID STENOSIS	0.0333333	15.141376475688356
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.0333333	15.141376475688356
CONGENITAL AORTIC VALVE STENOSIS	0.0333333	15.141376475688356
EISENMENGER SYNDROME	0.0333333	15.141376475688356
AORTO-VENTRICULAR TUNNEL	0.0333333	15.141376475688356
RING CHROMOSOME 7 SYNDROME	0.0333333	15.141376475688356
PARTIAL ATRIOVENTRICULAR CANAL	0.0333333	15.141376475688356
FAMILIAL ATRIAL MYXOMA	0.0333333	15.141376475688356
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.0333333	15.141376475688356
CARCINOID SYNDROME	0.0333333	15.141376475688356
PERIPARTUM CARDIOMYOPATHY	0.0333333	15.141376475688356
ANEURYSM OF SINUS OF VALSALVA	0.0333333	15.141376475688356
DOUBLE OUTLET RIGHT VENTRICLE	0.0333333	15.141376475688356
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.0333333	15.141376475688356
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.0333333	15.141376475688356
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	0.0333333	15.141376475688356
PULMONARY ARTERIOVENOUS MALFORMATION	0.0333333	15.141376475688356
FAMILIAL BICUSPID AORTIC VALVE	0.0333333	15.141376475688356
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.031078559999999998	14.11717943564751
KNIEST-LIKE DYSPLASIA, LETHAL	0.031078559999999998	14.11717943564751
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.028550452	12.968807237299323
ZELLWEGER SYNDROME	0.025644760000000003	11.648920622580835
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.025423404	11.548371486097125
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.024349950000000002	11.060763864189495
KAGAMI-OGATA SYNDROME	0.024292092000000005	11.034482345104065
RESTRICTIVE DERMOPATHY, LETHAL	0.0241836	10.985200749324457
HOLOPROSENCEPHALY	0.024024804	10.913068976627683
DISTAL MONOSOMY 15Q	0.023858454	10.837505861762645
RING CHROMOSOME 14 SYNDROME	0.023796732	10.809469152560961
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.023387104	10.623399013601324
YUNIS-VARON SYNDROME	0.023220754	10.547835898736286
KNIEST DYSPLASIA	0.02284155	10.375585610733392
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.022783692	10.349304091647962
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.022783692	10.349304091647962
KYPHOMELIC DYSPLASIA	0.0226752	10.300022495868353
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.0226752	10.300022495868353
LETHAL KNIEST-LIKE DYSPLASIA	0.0226752	10.300022495868353
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.0226752	10.300022495868353
48,XXYY SYNDROME	0.022459854	10.202203352293203
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.022398132	10.174166643091521
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.022238138	10.101490688780029
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.022238138	10.101490688780029
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.022238138	10.101490688780029
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.022238138	10.101490688780029
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.022238138	10.101490688780029
FAMILIAL LAMBDOID SYNOSTOSIS	0.0219143	9.95438994942527
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.021852578	9.926353240223587
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.021852578	9.926353240223587
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.021852578	9.926353240223587
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.021852578	9.926353240223587
SAUL-WILSON SYNDROME; SWILS	0.021822154	9.912533389266846
THANATOPHORIC DYSPLASIA, TYPE I	0.021822154	9.912533389266846
GRACILE BONE DYSPLASIA; GCLEB	0.021822154	9.912533389266846
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.021822154	9.912533389266846
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.021436594	9.737395940710405
THANATOPHORIC DYSPLASIA, TYPE II	0.0212766	9.664719986398913
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.0212766	9.664719986398913
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.0212766	9.664719986398913
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.0212766	9.664719986398913
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0212766	9.664719986398913
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.0212766	9.664719986398913
XYLT1-CDG	0.0212766	9.664719986398913
HYPOCHONDROPLASIA	0.0212766	9.664719986398913
DYSOSTEOSCLEROSIS	0.0212766	9.664719986398913
MELNICK-NEEDLES SYNDROME	0.0212766	9.664719986398913
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.0212766	9.664719986398913
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.0212766	9.664719986398913
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.0212766	9.664719986398913
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.0212766	9.664719986398913
JACOBSEN SYNDROME	0.021166488	9.614702518986714
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.020750504	9.425745219473534
VAN MALDERGEM SYNDROME 2; VMLDS2	0.020557768	9.338196481832247
VAN MALDERGEM SYNDROME 1; VMLDS1	0.020557768	9.338196481832247
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.02020495	9.1779318166056
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.020147092	9.151650297520169
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.020147092	9.151650297520169
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.020147092	9.151650297520169
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.019975434	9.073676067454029
MÃœLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.019601538	8.903836894652237
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.019601538	8.903836894652237
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.019601538	8.903836894652237
ADENYLOSUCCINATE LYASE DEFICIENCY	0.019601538	8.903836894652237
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.019351904	8.790442710004092
MAN1B1-CDG	0.019185554	8.714879595139054
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.019185554	8.714879595139054
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.019185554	8.714879595139054
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.018852281999999998	8.563493539128828
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.018852281999999998	8.563493539128828
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.018748492000000002	8.51634778805073
ANGELMAN SYNDROME	0.018748492000000002	8.51634778805073
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.01864	8.46706619227112
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.01864	8.46706619227112
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.01864	8.46706619227112
DUBOWITZ SYNDROME	0.018306728	8.315680136260898
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.018306728	8.315680136260898
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.018202938000000002	8.268534385182795
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.018202938000000002	8.268534385182795
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.018202938000000002	8.268534385182795
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.018202938000000002	8.268534385182795
TORIELLO-LACASSIE-DROSTE SYNDROME	0.01803128	8.190560155116653
MYHRE SYNDROME	0.017890744	8.126722836747714
FRONTOOCULAR SYNDROME	0.017890744	8.126722836747714
MARDEN-WALKER SYNDROME	0.017890744	8.126722836747714
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.017890744	8.126722836747714
HOLOPROSENCEPHALY 7	0.017786954	8.079577085669614
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.017786954	8.079577085669614
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.01734519	7.878909433879781
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.017287332	7.8526279147943505
CHROMOSOME 16Q22 DELETION SYNDROME	0.017287332	7.8526279147943505
DISTAL 17P13.1 MICRODELETION SYNDROME	0.0172414	7.831763682801679
OCULOCEREBRORENAL SYNDROME OF LOWE	0.0172414	7.831763682801679
PITT-HOPKINS-LIKE SYNDROME	0.0172414	7.831763682801679
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.0172414	7.831763682801679
BUSCHKE-OLLENDORFF SYNDROME	0.0172414	7.831763682801679
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.0172414	7.831763682801679
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0172414	7.831763682801679
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.0172414	7.831763682801679
FRONTONASAL DYSPLASIA	0.0172414	7.831763682801679
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.0172414	7.831763682801679
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.0172414	7.831763682801679
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.0172414	7.831763682801679
OPSISMODYSPLASIA	0.0172414	7.831763682801679
SCHIZOPHRENIA 1; SCZD1	0.0172414	7.831763682801679
CRANIOSYNOSTOSIS 4; CRS4	0.0172414	7.831763682801679
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.016908128	7.680377626791455
CAMPOMELIC DYSPLASIA	0.016741778	7.604814511926417
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.016741778	7.604814511926417
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.016741778	7.604814511926417
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.016741778	7.604814511926417
DUANE RETRACTION SYNDROME	0.016492144	7.491420327278273
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.016325794	7.415857212413236
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.016325794	7.415857212413236
DIGEORGE SYNDROME; DGS	0.016325794	7.415857212413236
HUNTER-MACDONALD SYNDROME	0.01594659	7.24360692441034
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.01594659	7.24360692441034
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.01594659	7.24360692441034
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.015888732	7.217325405324909
MEIER-GORLIN SYNDROME 1; MGORS1	0.01578024	7.168043809545302
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.01578024	7.168043809545302
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.01578024	7.168043809545302
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.01578024	7.168043809545302
113470 BRACHYMESOMELIA-RENAL SYNDROME	0.01578024	7.168043809545302
FEINGOLD SYNDROME 1; FGLDS1	0.01578024	7.168043809545302
CHROMOSOME 18Q DELETION SYNDROME	0.015343177999999999	6.969512002456975
%300712 CRANIOFACIOSKELETAL SYNDROME	0.014927194000000001	6.780554702943794
ADAMS-OLIVER SYNDROME 3; AOS3	0.014927194000000001	6.780554702943794
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.014927194000000001	6.780554702943794
ARTERIAL TORTUOSITY SYNDROME	0.014927194000000001	6.780554702943794
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.014927194000000001	6.780554702943794
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.01475698	6.703236397962504
LERI PLEONOSTEOSIS	0.014381640000000001	6.532741300075862
ZECHI-CEIDE SYNDROME	0.014381640000000001	6.532741300075862
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.014381640000000001	6.532741300075862
ECTRODACTYLY OF LOWER LIMBS, CONGENITAL HEART DEFECT, AND MICROGNATHIA	0.014381640000000001	6.532741300075862
OCULODENTODIGITAL DYSPLASIA; ODDD	0.014381640000000001	6.532741300075862
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.014381640000000001	6.532741300075862
%608572 BURN-MCKEOWN SYNDROME	0.014381640000000001	6.532741300075862
OROFACIODIGITAL SYNDROME XVI; OFD16	0.014179382	6.4408672725052405
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.014179381999999999	6.44086727250524
SIFRIM-HITZ-WEISS SYNDROME	0.013633828	6.193053869637306
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.013621814	6.187596609270678
KAGAMI-OGATA SYNDROME	0.013621814	6.187596609270678
2Q31.1 MICRODELETION SYNDROME	0.013217844	6.0040965701241245
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.013217844	6.0040965701241245
EMANUEL SYNDROME	0.012874002	5.847909178832125
WIEDEMANN-STEINER SYNDROME	0.012672290000000001	5.756283167256192
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.012614432	5.73000164817076
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.012614432	5.73000164817076
TARP SYNDROME; TARPS	0.012614432	5.73000164817076
CINCA SYNDROME	0.012598554000000001	5.722789197687882
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.012328448	5.600095775964191
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.012328448	5.600095775964191
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.012068878	5.482188245302827
FONTAINE PROGEROID SYNDROME; FPS	0.012068878	5.482188245302827
TYSHCHENKO SYNDROME	0.011912464000000001	5.4111384764510095
COSTELLO SYNDROME; CSTLO	0.011912464000000001	5.4111384764510095
FANCONI ANEMIA	0.011819244000000001	5.368794060654683
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.011819244	5.368794060654683
ZECHI-CEIDE SYNDROME	0.011652894	5.293230945789645
TOLUENE EMBRYOPATHY	0.011652894	5.293230945789645
SCHAAF-YANG SYNDROME; SHFYNG	0.011652894	5.293230945789645
INFANTILE SIALIC ACID STORAGE DISEASE	0.011475402	5.212606669362683
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.011309052	5.137043554497645
MCDONOUGH SYNDROME	0.011273690000000001	5.12098065778675
ACRO-RENAL-OCULAR SYNDROME	0.011273690000000001	5.12098065778675
CHROMOSOME 1P36 DELETION SYNDROME	0.011228232	5.100331736382873
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.011215832	5.094699138701319
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.011215832	5.094699138701319
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.011215832	5.094699138701319
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.011215832	5.094699138701319
TARP SYNDROME	0.011215832	5.094699138701319
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.011215832	5.094699138701319
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.011215832	5.094699138701319
IMMUNODEFICIENCY 49; IMD49	0.011215832	5.094699138701319
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.01110734	5.045417542921712
21Q22.11Q22.12 MICRODELETION SYNDROME	0.01110734	5.045417542921712
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.01110734	5.045417542921712
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.01110734	5.045417542921712
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.01110734	5.045417542921712
RESTRICTIVE DERMOPATHY	0.01110734	5.045417542921712
16P12.1P12.3 TRIPLICATION SYNDROME	0.01110734	5.045417542921712
YUNIS-VARON SYNDROME	0.010763498	4.889230151629712
JACOBSEN SYNDROME	0.010513864000000001	4.7758359669815675
CARDIOFACIOCUTANEOUS SYNDROME	0.010513864000000001	4.7758359669815675
VASCULAR EHLERS-DANLOS SYNDROME	0.010513864000000001	4.7758359669815675
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.010347514	4.70027285211653
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.010347514	4.70027285211653
DISTAL MONOSOMY 10Q	0.010347514	4.70027285211653
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.010254294	4.657928436320204
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.010254294	4.657928436320204
PETERS PLUS SYNDROME	0.010254294	4.657928436320204
6Q TERMINAL DELETION SYNDROME	0.010254294	4.657928436320204
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.010254294	4.657928436320204
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.009968310000000001	4.528022564113635
CORNELIA DE LANGE SYNDROME	0.009968310000000001	4.528022564113635
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.009910452	4.501741045028203
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.009910452	4.501741045028203
ROIFMAN SYNDROME; RFMN	0.009910452	4.501741045028203
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.009910452	4.501741045028203
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.009910452	4.501741045028203
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.009910452	4.501741045028203
3MC SYNDROME 1	0.009887489999999999	4.491310745998861
3MC SYNDROME 3	0.009887489999999999	4.491310745998861
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00980196	4.452459449248596
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00980196	4.452459449248596
GAUCHER DISEASE, PERINATAL LETHAL	0.00980196	4.452459449248596
GMS SYNDROME	0.00980196	4.452459449248596
INTERMEDIATE NEMALINE MYOPATHY	0.00980196	4.452459449248596
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00980196	4.452459449248596
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00980196	4.452459449248596
FEINGOLD SYNDROME	0.00970874	4.4101150334522705
FRONTONASAL DYSPLASIA 2; FND2	0.00970874	4.4101150334522705
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00970874	4.4101150334522705
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00970874	4.4101150334522705
PELVIS-SHOULDER DYSPLASIA	0.00970874	4.4101150334522705
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00970874	4.4101150334522705
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00970874	4.4101150334522705
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00970874	4.4101150334522705
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00970874	4.4101150334522705
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.009364898	4.25392764216027
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009364898	4.25392764216027
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.009364898	4.25392764216027
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009364898	4.25392764216027
NEMALINE MYOPATHY 10	0.009364898	4.25392764216027
TEMPLE SYNDROME	0.009364898	4.25392764216027
2P15P16.1 MICRODELETION SYNDROME	0.009143542000000001	4.153378505676559
PEDIATRIC-ONSET GRAVES DISEASE	0.008948914	4.064970342647088
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.008948914	4.064970342647088
GALLOWAY-MOWAT SYNDROME	0.008948914	4.064970342647088
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.008948914	4.064970342647088
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.008948914	4.064970342647088
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.008948914	4.064970342647088
FG SYNDROME TYPE 1	0.008948914	4.064970342647088
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.008948914	4.064970342647088
ROBERTS SYNDROME	0.008948914	4.064970342647088
CONGENITAL TOXOPLASMOSIS	0.008948914	4.064970342647088
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.008948914	4.064970342647088
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.008948914	4.064970342647088
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008948914	4.064970342647088
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.008948914	4.064970342647088
MARDEN-WALKER SYNDROME	0.008597988	3.9055651028086267
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.008597988	3.9055651028086267
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.008597988	3.9055651028086267
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	3.817156939779155
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	3.817156939779155
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00840336	3.817156939779155
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00840336	3.817156939779155
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	3.817156939779155
MICROFORM HOLOPROSENCEPHALY	0.00840336	3.817156939779155
DISTAL MONOSOMY 17Q	0.00840336	3.817156939779155
VACTERL/VATER ASSOCIATION	0.00840336	3.817156939779155
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	3.817156939779155
ADAMS-OLIVER SYNDROME	0.00840336	3.817156939779155
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	3.817156939779155
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	3.817156939779155
TEMPLE SYNDROME	0.00840336	3.817156939779155
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	3.817156939779155
HEC SYNDROME	0.00840336	3.817156939779155
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	3.817156939779155
PELIZAEUS-MERZBACHER DISEASE	0.00840336	3.817156939779155
CONGENITAL ANALBUMINEMIA	0.00840336	3.817156939779155
SILVER-RUSSELL SYNDROME	0.00840336	3.817156939779155
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	3.817156939779155
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	3.817156939779155
HYDROLETHALUS	0.00840336	3.817156939779155
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00840336	3.817156939779155
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	3.817156939779155
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	3.817156939779155
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	3.817156939779155
BECKWITH-WIEDEMANN SYNDROME	0.00840336	3.817156939779155
EBSTEIN MALFORMATION	0.00840336	3.817156939779155
BRONCHOPULMONARY DYSPLASIA	0.00840336	3.817156939779155
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	3.817156939779155
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	3.817156939779155
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	3.817156939779155
DIETHYLSTILBESTROL SYNDROME	0.00840336	3.817156939779155
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00840336	3.817156939779155
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.00840336	3.817156939779155
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	3.817156939779155
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	3.817156939779155
OMPHALOCELE	0.00840336	3.817156939779155
SCHISIS ASSOCIATION	0.00840336	3.817156939779155
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	3.817156939779155
PEMPHIGOID GESTATIONIS	0.00840336	3.817156939779155
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.00840336	3.817156939779155
DIAMOND-BLACKFAN ANEMIA 1	0.00840336	3.817156939779155
RENAL TUBULAR DYSGENESIS	0.00840336	3.817156939779155
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	3.817156939779155
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	3.817156939779155
FATCO SYNDROME	0.00840336	3.817156939779155
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	3.817156939779155
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	3.817156939779155
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	3.817156939779155
CLASSICAL EHLERS-DANLOS SYNDROME	0.00840336	3.817156939779155
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	3.817156939779155
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	3.817156939779155
RETINOPATHY OF PREMATURITY	0.00840336	3.817156939779155
14Q12 MICRODELETION SYNDROME	0.00832254	3.7804451216643824
HARDIKAR SYNDROME	0.00832254	3.7804451216643824
DISTAL TRISOMY 6P	0.008182004	3.716607803295444
JOUBERT SYNDROME 14	0.008120282	3.6885710940937613
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0077449419999999995	3.5180759962071178
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.0077449419999999995	3.5180759962071178
KOOLEN-DE VRIES SYNDROME; KDVS	0.0077449419999999995	3.5180759962071178
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.0076364499999999995	3.4687944004275106
3MC SYNDROME	0.0076364499999999995	3.4687944004275106
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.0076364499999999995	3.4687944004275106
8Q21.11 MICRODELETION SYNDROME	0.0076364499999999995	3.4687944004275106
WIEDEMANN-STEINER SYNDROME; WDSTS	0.0075785919999999994	3.44251288134208
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0075785919999999994	3.44251288134208
MICROPHTHALMIA, SYNDROMIC 1	0.007574728	3.4407576912258286
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.007199388	3.2702625933391847
OHDO SYNDROME	0.007199388	3.2702625933391847
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.007033038	3.1946994784741474
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.007033038	3.1946994784741474
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.007033038	3.1946994784741474
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.006783404	3.0813052938260026
MOSAIC TRISOMY 14	0.006783404	3.0813052938260026
KOOLEN-DE VRIES SYNDROME	0.006783404	3.0813052938260026
3MC SYNDROME 2	0.006783404	3.0813052938260026
COACH SYNDROME	0.006721682	3.05326858462432
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.006721682	3.05326858462432
CHROMOSOME 5Q12 DELETION SYNDROME	0.006721682	3.05326858462432
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.006721682	3.05326858462432
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.006617054	3.005742178960965
16P11.2P12.2 MICRODELETION SYNDROME	0.006617054	3.005742178960965
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.006617054	3.005742178960965
8Q22.1 MICRODELETION SYNDROME	0.006617054	3.005742178960965
MONOSOMY 9P	0.006617054	3.005742178960965
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.006555332	2.9777054697592824
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.006555332	2.9777054697592824
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.006555332	2.9777054697592824
HEART AND BRAIN MALFORMATION SYNDROME	0.006555332	2.9777054697592824
ADENYLOSUCCINASE DEFICIENCY	0.006555332	2.9777054697592824
VICI SYNDROME; VICIS	0.006555332	2.9777054697592824
RECOMBINANT CHROMOSOME 8 SYNDROME	0.006555332	2.9777054697592824
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00623785	2.833491890958069
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00623785	2.833491890958069
TRISOMY XQ28	0.00623785	2.833491890958069
DUBOWITZ SYNDROME	0.00623785	2.833491890958069
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00623785	2.833491890958069
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.00623785	2.833491890958069
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00623785	2.833491890958069
ASCHER SYNDROME	0.00623785	2.833491890958069
SCHWARTZ-JAMPEL SYNDROME	0.00623785	2.833491890958069
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.00623785	2.833491890958069
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00623785	2.833491890958069
FRONTOFACIONASAL DYSPLASIA	0.00623785	2.833491890958069
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00623785	2.833491890958069
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.00623785	2.833491890958069
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00623785	2.833491890958069
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00623785	2.833491890958069
DISTAL TRISOMY 15Q	0.00623785	2.833491890958069
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00623785	2.833491890958069
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00623785	2.833491890958069
DISTAL MONOSOMY 3P	0.00623785	2.833491890958069
LATHOSTEROLOSIS	0.006176128	2.805455181756387
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.0060715	2.7579287760930318
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.0060715	2.7579287760930318
PELVISCAPULAR DYSPLASIA	0.0060715	2.7579287760930318
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.0060715	2.7579287760930318
ACROOTOOCULAR SYNDROME	0.0060715	2.7579287760930318
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0060715	2.7579287760930318
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0060715	2.7579287760930318
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0060715	2.7579287760930318
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.0060715	2.7579287760930318
FRYNS SYNDROME; FRNS	0.0060715	2.7579287760930318
SECKEL SYNDROME 1; SCKL1	0.0060715	2.7579287760930318
TRISOMY 18-LIKE SYNDROME	0.0060715	2.7579287760930318
SIMOSA CRANIOFACIAL SYNDROME	0.0060715	2.7579287760930318
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.006009778	2.7298920668913493
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.005760144	2.616497882243205
22Q11.2 MICRODUPLICATION SYNDROME	0.005760144	2.616497882243205
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.005634438	2.5593969690047054
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.005634438	2.5593969690047054
WILLIAMS-BEUREN SYNDROME; WBS	0.005634438	2.5593969690047054
ARTERIAL TORTUOSITY SYNDROME	0.005634438	2.5593969690047054
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.005634438	2.5593969690047054
GLYCEROL KINASE DEFICIENCY; GKD	0.005593794	2.5409347673781677
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.005593794	2.5409347673781677
JOUBERT SYNDROME 10	0.005593794	2.5409347673781677
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.005593794	2.5409347673781677
RING CHROMOSOME 12 SYNDROME	0.005593794	2.5409347673781677
49,XXXXY SYNDROME	0.005218454	2.3704396694915237
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.005218454	2.3704396694915237
DISTAL TRISOMY 17Q	0.005218454	2.3704396694915237
8P11.2 DELETION SYNDROME	0.005218454	2.3704396694915237
CHROMOSOME 2Q37 DELETION SYNDROME	0.005218454	2.3704396694915237
48,XXXY SYNDROME	0.005218454	2.3704396694915237
TRISOMY 18	0.005218454	2.3704396694915237
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.005218454	2.3704396694915237
CURRY-JONES SYNDROME	0.005218454	2.3704396694915237
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.005218454	2.3704396694915237
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.005218454	2.3704396694915237
CEREBROFACIOARTICULAR SYNDROME	0.005218454	2.3704396694915237
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.005218454	2.3704396694915237
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.005218454	2.3704396694915237
PSEUDOAMINOPTERIN SYNDROME	0.005218454	2.3704396694915237
HYPOTONIA-CYSTINURIA SYNDROME	0.00521459	2.3686844793752715
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00521459	2.3686844793752715
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00521459	2.3686844793752715
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.005156732000000001	2.3424029602898413
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.005156732000000001	2.3424029602898413
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.005156732000000001	2.3424029602898413
WITTEVEEN-KOLK SYNDROME	0.005156732000000001	2.3424029602898413
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.005156732000000001	2.3424029602898413
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.005156732000000001	2.3424029602898413
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.005156732000000001	2.3424029602898413
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.005156732000000001	2.3424029602898413
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.005156732000000001	2.3424029602898413
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.005156732000000001	2.3424029602898413
SALLA DISEASE	0.005156732000000001	2.3424029602898413
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.005156732000000001	2.3424029602898413
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.005156732	2.3424029602898413
RING CHROMOSOME 22 SYNDROME	0.005156732	2.3424029602898413
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.005156732	2.3424029602898413
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.005156732	2.3424029602898413
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.005156732	2.3424029602898413
KLEEFSTRA SYNDROME 2; KLEFS2	0.005156732	2.3424029602898413
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.005156732	2.3424029602898413
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.005156732	2.3424029602898413
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.005156732	2.3424029602898413
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.005156732	2.3424029602898413
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.005156732	2.3424029602898413
CRI-DU-CHAT SYNDROME	0.00504824	2.2931213645102337
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00504824	2.2931213645102337
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00504824	2.2931213645102337
JUVENILE POLYPOSIS SYNDROME	0.00504824	2.2931213645102337
BRADDOCK SYNDROME	0.0046729	2.1226262666235898
OTOMANDIBULAR SYNDROME	0.0046729	2.1226262666235898
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0046729	2.1226262666235898
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.0046729	2.1226262666235898
FETAL AKINESIA SYNDROME, X-LINKED	0.0046729	2.1226262666235898
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.0046729	2.1226262666235898
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, MKB TYPE	0.0046729	2.1226262666235898
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.0046729	2.1226262666235898
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.0046729	2.1226262666235898
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.0046729	2.1226262666235898
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.0046729	2.1226262666235898
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.0046729	2.1226262666235898
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.0046729	2.1226262666235898
ANOPHTHALMIA PLUS SYNDROME	0.0046729	2.1226262666235898
PFEIFFER-PALM-TELLER SYNDROME	0.0046729	2.1226262666235898
HEMIFACIAL MICROSOMIA	0.0046729	2.1226262666235898
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.0046729	2.1226262666235898
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.0046729	2.1226262666235898
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.0046729	2.1226262666235898
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.0046729	2.1226262666235898
TRIOPIA	0.0046729	2.1226262666235898
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.0046729	2.1226262666235898
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0046729	2.1226262666235898
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.0046729	2.1226262666235898
WAARDENBURG SYNDROME, TYPE 1; WS1	0.0046729	2.1226262666235898
VELOCARDIOFACIAL SYNDROME	0.0046729	2.1226262666235898
MENTAL RETARDATION, X-LINKED 92	0.0046729	2.1226262666235898
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0046729	2.1226262666235898
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.0046729	2.1226262666235898
WILLIAMS SYNDROME	0.0046729	2.1226262666235898
MICROPHTHALMIA WITH LIMB ANOMALIES	0.0046729	2.1226262666235898
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0046729	2.1226262666235898
WARBURG MICRO SYNDROME 3; WARBM3	0.0046729	2.1226262666235898
WAARDENBURG SYNDROME TYPE 3	0.0046729	2.1226262666235898
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.0046729	2.1226262666235898
TRISOMY 4P	0.0046729	2.1226262666235898
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.0046729	2.1226262666235898
SECKEL SYNDROME 5; SCKL5	0.0046729	2.1226262666235898
NON-DISTAL TRISOMY 10Q	0.0046729	2.1226262666235898
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.0046729	2.1226262666235898
RAPADILINO SYNDROME	0.0046729	2.1226262666235898
PFEIFFER-PALM-TELLER SYNDROME	0.0046729	2.1226262666235898
DERMOTRICHIC SYNDROME	0.0046729	2.1226262666235898
TOWNES-BROCKS SYNDROME	0.0046729	2.1226262666235898
OMODYSPLASIA 1; OMOD1	0.0046729	2.1226262666235898
TRISOMY 18P	0.0046729	2.1226262666235898
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.0046729	2.1226262666235898
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.0046729	2.1226262666235898
CLEFT PALATE-LATERAL SYNECHIA SYNDROME	0.0046729	2.1226262666235898
14Q11.2 MICRODELETION SYNDROME	0.0046729	2.1226262666235898
NEONATAL HEMOCHROMATOSIS	0.0046729	2.1226262666235898
3P25.3 MICRODELETION SYNDROME	0.0046729	2.1226262666235898
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.0046729	2.1226262666235898
TRISOMY 20P	0.0046729	2.1226262666235898
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.0046729	2.1226262666235898
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.0046111780000000005	2.094589557421908
SENGERS SYNDROME	0.0046111780000000005	2.094589557421908
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.0046111780000000005	2.094589557421908
ACETYL-COA CARBOXYLASE DEFICIENCY	0.0046111780000000005	2.094589557421908
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0046111780000000005	2.094589557421908
CYCLIC VOMITING SYNDROME	0.0046111780000000005	2.094589557421908
GLYCOGEN STORAGE DISEASE IXC	0.0046111780000000005	2.094589557421908
RING CHROMOSOME 13 SYNDROME	0.0046111780000000005	2.094589557421908
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0046111780000000005	2.094589557421908
ACROCALLOSAL SYNDROME; ACLS	0.0046111780000000005	2.094589557421908
DUPLICATION/INVERSION 15Q11	0.0046111780000000005	2.094589557421908
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.0046111780000000005	2.094589557421908
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0046111780000000005	2.094589557421908
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0046111780000000005	2.094589557421908
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0046111780000000005	2.094589557421908
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0046111780000000005	2.094589557421908
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.0046111780000000005	2.094589557421908
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.0046111780000000005	2.094589557421908
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0046111780000000005	2.094589557421908
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.004470642	2.0307522390529695
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.004470642	2.0307522390529695
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.004470642	2.0307522390529695
COHEN-GIBSON SYNDROME; COGIS	0.004470642	2.0307522390529695
JOUBERT SYNDROME 35; JBTS35	0.004470642	2.0307522390529695
NOONAN SYNDROME 11; NS11	0.004470642	2.0307522390529695
HADZISELIMOVIC SYNDROME	0.004470642	2.0307522390529695
WIEACKER-WOLFF SYNDROME	0.004470642	2.0307522390529695
BARAITSER-WINTER SYNDROME 1; BRWS1	0.004470642	2.0307522390529695
SHASHI-PENA SYNDROME; SHAPNS	0.004470642	2.0307522390529695
JOUBERT SYNDROME 1	0.004470642	2.0307522390529695
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.004470642	2.0307522390529695
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.004470642	2.0307522390529695
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.004470642	2.0307522390529695
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.004470642	2.0307522390529695
GOLDBERG-SHPRINTZEN SYNDROME	0.004470642	2.0307522390529695
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.004195194	1.9056322579087261
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.004195194	1.9056322579087261
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.004195194	1.9056322579087261
MONOSOMY 13Q34	0.004195194	1.9056322579087261
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.004195194	1.9056322579087261
CLASSIC PHENYLKETONURIA	0.004195194	1.9056322579087261
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.004195194	1.9056322579087261
BIOTINIDASE DEFICIENCY	0.004195194	1.9056322579087261
COG4-CDG	0.004195194	1.9056322579087261
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.004195194	1.9056322579087261
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.004195194	1.9056322579087261
ABLEPHARON MACROSTOMIA SYNDROME	0.004195194	1.9056322579087261
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.004195194	1.9056322579087261
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.004195194	1.9056322579087261
THYROID HEMIAGENESIS	0.004195194	1.9056322579087261
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.004195194	1.9056322579087261
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.004195194	1.9056322579087261
XP21 MICRODELETION SYNDROME	0.004195194	1.9056322579087261
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.004195194	1.9056322579087261
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004195194	1.9056322579087261
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.004195194	1.9056322579087261
GALACTOSEMIA	0.004195194	1.9056322579087261
LIG4 SYNDROME	0.004195194	1.9056322579087261
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.004195194	1.9056322579087261
OCULOECTODERMAL SYNDROME; OES	0.004195194	1.9056322579087261
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.004195194	1.9056322579087261
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.004195194	1.9056322579087261
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.004195194	1.9056322579087261
GALACTOSE EPIMERASE DEFICIENCY	0.004195194	1.9056322579087261
NEPHRONOPHTHISIS 11; NPHP11	0.004195194	1.9056322579087261
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.004195194	1.9056322579087261
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.004195194	1.9056322579087261
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.004195194	1.9056322579087261
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.004195194	1.9056322579087261
OPTIC PATHWAY GLIOMA	0.004195194	1.9056322579087261
MENTAL RETARDATION, X-LINKED 98; MRX98	0.004195194	1.9056322579087261
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.004195194	1.9056322579087261
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.004195194	1.9056322579087261
WOLMAN DISEASE	0.004195194	1.9056322579087261
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.004195194	1.9056322579087261
X SMALL RINGS	0.004195194	1.9056322579087261
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.004195194	1.9056322579087261
2P21 MICRODELETION SYNDROME	0.004195194	1.9056322579087261
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.003925088	1.782938836185036
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.003925088	1.782938836185036
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.003925088	1.782938836185036
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.003925088	1.782938836185036
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.003925088	1.782938836185036
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.003925088	1.782938836185036
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.003925088	1.782938836185036
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.003925088	1.782938836185036
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.003925088	1.782938836185036
JOUBERT SYNDROME 3; JBTS3	0.003925088	1.782938836185036
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.003925088	1.782938836185036
LATERAL MENINGOCELE SYNDROME	0.003925088	1.782938836185036
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.003925088	1.782938836185036
SPINOCEREBELLAR ATAXIA 47; SCA47	0.003925088	1.782938836185036
VERVERI-BRADY SYNDROME; VERBRAS	0.003925088	1.782938836185036
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00364964	1.6578188550407924
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.00364964	1.6578188550407924
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.00364964	1.6578188550407924
NEPHRONOPHTHISIS 4	0.00364964	1.6578188550407924
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00364964	1.6578188550407924
CRYPTOSPORIDIOSIS	0.00364964	1.6578188550407924
SERKAL SYNDROME	0.00364964	1.6578188550407924
ROTHMUND-THOMSON SYNDROME TYPE 2	0.00364964	1.6578188550407924
FAMILIAL HYPOALDOSTERONISM	0.00364964	1.6578188550407924
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.00364964	1.6578188550407924
CINCA SYNDROME; CINCA	0.00364964	1.6578188550407924
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00364964	1.6578188550407924
ESOPHAGEAL ATRESIA	0.00364964	1.6578188550407924
INTESTINAL LYMPHANGIECTASIA	0.00364964	1.6578188550407924
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00364964	1.6578188550407924
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00364964	1.6578188550407924
FAMILIAL DYSAUTONOMIA	0.00364964	1.6578188550407924
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00364964	1.6578188550407924
DIAMOND-BLACKFAN ANEMIA 9	0.00364964	1.6578188550407924
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.00364964	1.6578188550407924
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00364964	1.6578188550407924
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.00364964	1.6578188550407924
CERNUNNOS-XLF DEFICIENCY	0.00364964	1.6578188550407924
2Q24 MICRODELETION SYNDROME	0.00364964	1.6578188550407924
EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM	0.00364964	1.6578188550407924
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00364964	1.6578188550407924
MAJEED SYNDROME	0.00364964	1.6578188550407924
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00364964	1.6578188550407924
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00364964	1.6578188550407924
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.00364964	1.6578188550407924
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.00364964	1.6578188550407924
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.00364964	1.6578188550407924
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.00364964	1.6578188550407924
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00364964	1.6578188550407924
COLOBOMA, OCULAR	0.00364964	1.6578188550407924
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.00364964	1.6578188550407924
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00364964	1.6578188550407924
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00364964	1.6578188550407924
ZIMMERMANN-LABAND SYNDROME	0.00364964	1.6578188550407924
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IGE; EPKHE	0.00364964	1.6578188550407924
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.00364964	1.6578188550407924
HEREDITARY FRUCTOSE INTOLERANCE	0.00364964	1.6578188550407924
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00364964	1.6578188550407924
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00364964	1.6578188550407924
GENERALIZED JUVENILE POLYPOSIS/JUVENILE POLYPOSIS COLI	0.00364964	1.6578188550407924
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.00364964	1.6578188550407924
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00364964	1.6578188550407924
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00364964	1.6578188550407924
CHYLOMICRON RETENTION DISEASE	0.00364964	1.6578188550407924
ACHALASIA-MICROCEPHALY SYNDROME	0.00364964	1.6578188550407924
CHYLOMICRON RETENTION DISEASE	0.00364964	1.6578188550407924
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00364964	1.6578188550407924
GAPO SYNDROME; GAPOS	0.00364964	1.6578188550407924
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00364964	1.6578188550407924
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00364964	1.6578188550407924
FORMIMINOTRANSFERASE DEFICIENCY	0.00364964	1.6578188550407924
LYSINE MALABSORPTION SYNDROME	0.00364964	1.6578188550407924
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00364964	1.6578188550407924
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00364964	1.6578188550407924
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00364964	1.6578188550407924
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00364964	1.6578188550407924
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.00364964	1.6578188550407924
HEREDITARY SPHEROCYTOSIS	0.00364964	1.6578188550407924
BARTH SYNDROME; BTHS	0.00364964	1.6578188550407924
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.00364964	1.6578188550407924
ALPHA-HEAVY CHAIN DISEASE	0.00364964	1.6578188550407924
ROWLEY-ROSENBERG SYNDROME	0.00364964	1.6578188550407924
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.00364964	1.6578188550407924
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00364964	1.6578188550407924
AROMATASE DEFICIENCY	0.00364964	1.6578188550407924
TYROSINE TRANSAMINASE DEFICIENCY	0.00364964	1.6578188550407924
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00364964	1.6578188550407924
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.00364964	1.6578188550407924
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00364964	1.6578188550407924
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.00364964	1.6578188550407924
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00364964	1.6578188550407924
THREONINEMIA	0.00364964	1.6578188550407924
EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE K14	0.00364964	1.6578188550407924
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.00364964	1.6578188550407924
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00364964	1.6578188550407924
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00364964	1.6578188550407924
OSTEOPETROSIS AND RELATED DISORDERS	0.00364964	1.6578188550407924
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.00364964	1.6578188550407924
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.00364964	1.6578188550407924
AXENFELD-RIEGER SYNDROME	0.00364964	1.6578188550407924
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.00364964	1.6578188550407924
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00364964	1.6578188550407924
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.00364964	1.6578188550407924
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00364964	1.6578188550407924
GLYCOGEN STORAGE DISEASE IXA	0.00364964	1.6578188550407924
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00364964	1.6578188550407924
CITRULLINE TRANSPORT DEFECT	0.00364964	1.6578188550407924
SECONDARY SHORT BOWEL SYNDROME	0.00364964	1.6578188550407924
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00364964	1.6578188550407924
NEPHRONOPHTHISIS 1	0.00364964	1.6578188550407924
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00364964	1.6578188550407924
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.00364964	1.6578188550407924
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.00364964	1.6578188550407924
DIARRHEA 2, WITH MICROVILLOUS ATROPHY	0.00364964	1.6578188550407924
CUSHING SYNDROME	0.00364964	1.6578188550407924
NATHALIE SYNDROME	0.00364964	1.6578188550407924
MEHMO SYNDROME	0.00364964	1.6578188550407924
MILLER-DIEKER SYNDROME	0.00364964	1.6578188550407924
LINEAR NEVUS SEBACEUS SYNDROME	0.00364964	1.6578188550407924
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00364964	1.6578188550407924
20Q13.33 MICRODELETION SYNDROME	0.00364964	1.6578188550407924
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.00364964	1.6578188550407924
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.00364964	1.6578188550407924
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.00364964	1.6578188550407924
T-SUBSTANCE ANOMALY	0.00364964	1.6578188550407924
COFFIN-SIRIS SYNDROME 1; CSS1	0.003509104	1.593981536671854
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.003509104	1.593981536671854
CUTIS LAXA	0.003509104	1.593981536671854
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.003509104	1.593981536671854
11Q22.2Q22.3 MICRODELETION SYNDROME	0.003509104	1.593981536671854
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.003509104	1.593981536671854
AICARDI-GOUTIÃˆRES SYNDROME	0.003509104	1.593981536671854
PETERS-PLUS SYNDROME; PTRPLS	0.003509104	1.593981536671854
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.003509104	1.593981536671854
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.003509104	1.593981536671854
LATERAL MENINGOCELE SYNDROME	0.003509104	1.593981536671854
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.003509104	1.593981536671854
CREE MENTAL RETARDATION SYNDROME	0.003509104	1.593981536671854
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.003509104	1.593981536671854
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.003509104	1.593981536671854
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.003509104	1.593981536671854
FETAL TRIMETHADIONE SYNDROME	0.003509104	1.593981536671854
OKAMOTO SYNDROME	0.003509104	1.593981536671854
CHAR SYNDROME	0.003509104	1.593981536671854
NOONAN SYNDROME 5; NS5	0.003509104	1.593981536671854
PERLMAN SYNDROME	0.003509104	1.593981536671854
22Q11.2 DELETION SYNDROME	0.003509104	1.593981536671854
RUBINSTEIN-TAYBI SYNDROME	0.003509104	1.593981536671854
TRISOMY 17P	0.003509104	1.593981536671854
JOUBERT SYNDROME	0.003509104	1.593981536671854
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.003509104	1.593981536671854
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.003072042	1.3954497295835278
CODAS SYNDROME	0.003072042	1.3954497295835278
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.003072042	1.3954497295835278
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.003072042	1.3954497295835278
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.003072042	1.3954497295835278
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.003072042	1.3954497295835278
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.003072042	1.3954497295835278
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.003072042	1.3954497295835278
HELSMOORTEL-VAN DER AA SYNDROME	0.003072042	1.3954497295835278
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.003072042	1.3954497295835278
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.003072042	1.3954497295835278
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.003072042	1.3954497295835278
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.003072042	1.3954497295835278
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.003072042	1.3954497295835278
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.003072042	1.3954497295835278
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.003072042	1.3954497295835278
ARIMA SYNDROME	0.003072042	1.3954497295835278
JOUBERT SYNDROME 26	0.003072042	1.3954497295835278
HYPOTONIA-CYSTINURIA SYNDROME	0.003072042	1.3954497295835278
LEIGH SYNDROME; LS	0.003072042	1.3954497295835278
JOUBERT SYNDROME 7	0.003072042	1.3954497295835278
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.003072042	1.3954497295835278
JOUBERT SYNDROME 21	0.003072042	1.3954497295835278
AU-KLINE SYNDROME; AUKS	0.003072042	1.3954497295835278
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.003072042	1.3954497295835278
CRANIOSYNOSTOSIS 6; CRS6	0.003072042	1.3954497295835278
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.003072042	1.3954497295835278
AURICULOCONDYLAR SYNDROME	0.003072042	1.3954497295835278
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.003072042	1.3954497295835278
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.003072042	1.3954497295835278
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.003072042	1.3954497295835278
KABUKI SYNDROME 1	0.003072042	1.3954497295835278
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.003072042	1.3954497295835278
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.003072042	1.3954497295835278
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.003072042	1.3954497295835278
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.003072042	1.3954497295835278
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.003072042	1.3954497295835278
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.003072042	1.3954497295835278
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.003072042	1.3954497295835278
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.003072042	1.3954497295835278
JOUBERT SYNDROME 30; JBTS30	0.003072042	1.3954497295835278
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.003072042	1.3954497295835278
PONTINE TEGMENTAL CAP DYSPLASIA	0.003072042	1.3954497295835278
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.003072042	1.3954497295835278
PHELAN-MCDERMID SYNDROME	0.003072042	1.3954497295835278
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.003072042	1.3954497295835278
TEEBI-SHALTOUT SYNDROME; TBSH	0.0029635499999999997	1.3461681338039204
TURNER SYNDROME	0.0029635499999999997	1.3461681338039204
MEIER-GORLIN SYNDROME 8; MGORS8	0.0029635499999999997	1.3461681338039204
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.0029635499999999997	1.3461681338039204
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.0029635499999999997	1.3461681338039204
FRONTONASAL DYSPLASIA 1; FND1	0.0029635499999999997	1.3461681338039204
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0029635499999999997	1.3461681338039204
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.0029635499999999997	1.3461681338039204
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.0029635499999999997	1.3461681338039204
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.0029635499999999997	1.3461681338039204
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.0029635499999999997	1.3461681338039204
MONOSOMY X	0.0029635499999999997	1.3461681338039204
BRANCHIOOCULOFACIAL SYNDROME	0.0029635499999999997	1.3461681338039204
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.0029635499999999997	1.3461681338039204
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.0029635499999999997	1.3461681338039204
MOSAIC MONOSOMY X	0.0029635499999999997	1.3461681338039204
CORNELIA DE LANGE SYNDROME 1	0.0029635499999999997	1.3461681338039204
NEUROFACIODIGITORENAL SYNDROME	0.0029635499999999997	1.3461681338039204
SAETHRE-CHOTZEN SYNDROME	0.0029635499999999997	1.3461681338039204
HYPERTELORISM, TEEBI TYPE	0.0029635499999999997	1.3461681338039204
CONGENITAL MYASTHENIC SYNDROME	0.0029635499999999997	1.3461681338039204
TERMINAL OSSEOUS DYSPLASIA; TOD	0.0029635499999999997	1.3461681338039204
4Q21 MICRODELETION SYNDROME	0.0029635499999999997	1.3461681338039204
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.0029635499999999997	1.3461681338039204
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.0029635499999999997	1.3461681338039204
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.0029635499999999997	1.3461681338039204
GABRIELE-DE VRIES SYNDROME	0.0029635499999999997	1.3461681338039204
POLYVALVULAR HEART DISEASE SYNDROME	0.0029635499999999997	1.3461681338039204
MONOSOMY 13Q14	0.0029635499999999997	1.3461681338039204
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.0029635499999999997	1.3461681338039204
SCARF SYNDROME	0.0029635499999999997	1.3461681338039204
WIDOW'S PEAK SYNDROME	0.0029635499999999997	1.3461681338039204
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0029635499999999997	1.3461681338039204
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.0029635499999999997	1.3461681338039204
PROTEUS SYNDROME	0.0029635499999999997	1.3461681338039204
AYME-GRIPP SYNDROME; AYGRP	0.0029635499999999997	1.3461681338039204
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.0029635499999999997	1.3461681338039204
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.0029635499999999997	1.3461681338039204
NOONAN SYNDROME 8; NS8	0.0029635499999999997	1.3461681338039204
SHPRINTZEN-GOLDBERG SYNDROME	0.0029635499999999997	1.3461681338039204
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.0029635499999999997	1.3461681338039204
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0029056919999999997	1.31988661471849
JABERI-ELAHI SYNDROME; JABELS	0.0029056919999999997	1.31988661471849
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0029056919999999997	1.31988661471849
OROFACIODIGITAL SYNDROME VI	0.0029056919999999997	1.31988661471849
AL-RAQAD SYNDROME; ARS	0.0029056919999999997	1.31988661471849
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.0029056919999999997	1.31988661471849
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0029056919999999997	1.31988661471849
MEND SYNDROME	0.0029056919999999997	1.31988661471849
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.0029056919999999997	1.31988661471849
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.0029056919999999997	1.31988661471849
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0029056919999999997	1.31988661471849
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.0029056919999999997	1.31988661471849
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0029056919999999997	1.31988661471849
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0029056919999999997	1.31988661471849
NOONAN SYNDROME 6; NS6	0.0029056919999999997	1.31988661471849
WHITE-SUTTON SYNDROME; WHSUS	0.0029056919999999997	1.31988661471849
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0029056919999999997	1.31988661471849
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.0029056919999999997	1.31988661471849
OROFACIODIGITAL SYNDROME XIV; OFD14	0.0029056919999999997	1.31988661471849
C SYNDROME	0.0029056919999999997	1.31988661471849
SIALURIA	0.0029056919999999997	1.31988661471849
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0029056919999999997	1.31988661471849
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.0029056919999999997	1.31988661471849
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0029056919999999997	1.31988661471849
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.0029056919999999997	1.31988661471849
XIA-GIBBS SYNDROME	0.0029056919999999997	1.31988661471849
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0029056919999999997	1.31988661471849
RITSCHER-SCHINZEL SYNDROME 1	0.0029056919999999997	1.31988661471849
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0029056919999999997	1.31988661471849
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.0029056919999999997	1.31988661471849
DISTAL MONOSOMY 12Q	0.0029056919999999997	1.31988661471849
AL KAISSI SYNDROME; ALKAS	0.0029056919999999997	1.31988661471849
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.0029056919999999997	1.31988661471849
TEMTAMY SYNDROME; TEMTYS	0.0029056919999999997	1.31988661471849
COFFIN-SIRIS SYNDROME 7; CSS7	0.0029056919999999997	1.31988661471849
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.0029056919999999997	1.31988661471849
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0029056919999999997	1.31988661471849
MEVALONIC ACIDURIA; MEVA	0.0029056919999999997	1.31988661471849
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.0029056919999999997	1.31988661471849
CHROMOSOME 10Q26 DELETION SYNDROME	0.0029056919999999997	1.31988661471849
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0029056919999999997	1.31988661471849
LAMB-SHAFFER SYNDROME	0.0029056919999999997	1.31988661471849
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.0029056919999999997	1.31988661471849
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0029056919999999997	1.31988661471849
CHROMOSOME 16P13.2 DELETION SYNDROME	0.0029056919999999997	1.31988661471849
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0029056919999999997	1.31988661471849
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0029056919999999997	1.31988661471849
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.0029056919999999997	1.31988661471849
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.0029056919999999997	1.31988661471849
ADAMS-OLIVER SYNDROME 2; AOS2	0.0029056919999999997	1.31988661471849
OGDEN SYNDROME	0.0029056919999999997	1.31988661471849
EMANUEL SYNDROME	0.0029056919999999997	1.31988661471849
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.0029056919999999997	1.31988661471849
JOUBERT SYNDROME 2	0.0029056919999999997	1.31988661471849
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.0029056919999999997	1.31988661471849
ZTTK SYNDROME; ZTTKS	0.0029056919999999997	1.31988661471849
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.0029056919999999997	1.31988661471849
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0029056919999999997	1.31988661471849
LARSEN-LIKE SYNDROME	0.0029056919999999997	1.31988661471849
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0029056919999999997	1.31988661471849
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.0029056919999999997	1.31988661471849
BOHRING-OPITZ SYNDROME	0.0029056919999999997	1.31988661471849
MEND SYNDROME; MEND	0.0029056919999999997	1.31988661471849
PEROXISOME BIOGENESIS DISORDER 10B	0.0029056919999999997	1.31988661471849
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0029056919999999997	1.31988661471849
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0029056919999999997	1.31988661471849
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0029056919999999997	1.31988661471849
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.0029056919999999997	1.31988661471849
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0029056919999999997	1.31988661471849
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0029056919999999997	1.31988661471849
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.0029056919999999997	1.31988661471849
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0029056919999999997	1.31988661471849
DIAPHANOSPONDYLODYSOSTOSIS	0.0029056919999999997	1.31988661471849
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.0029056919999999997	1.31988661471849
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.0029056919999999997	1.31988661471849
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.0029056919999999997	1.31988661471849
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0029056919999999997	1.31988661471849
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.0029056919999999997	1.31988661471849
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0025264880000000003	1.1476363267155945
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.0025264880000000003	1.1476363267155945
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.0025264880000000003	1.1476363267155945
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0025264880000000003	1.1476363267155945
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0025264880000000003	1.1476363267155945
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.0025264880000000003	1.1476363267155945
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.0025264880000000003	1.1476363267155945
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0025264880000000003	1.1476363267155945
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.0025264880000000003	1.1476363267155945
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0025264880000000003	1.1476363267155945
MYASTHENIC SYNDROME, CONGENITAL, 13	0.0025264880000000003	1.1476363267155945
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0025264880000000003	1.1476363267155945
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.0025264880000000003	1.1476363267155945
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0025264880000000003	1.1476363267155945
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0025264880000000003	1.1476363267155945
COFFIN-SIRIS SYNDROME 8; CSS8	0.0025264880000000003	1.1476363267155945
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0025264880000000003	1.1476363267155945
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0025264880000000003	1.1476363267155945
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.0025264880000000003	1.1476363267155945
PALLISTER-KILLIAN SYNDROME	0.0025264880000000003	1.1476363267155945
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0025264880000000003	1.1476363267155945
PRIMROSE SYNDROME; PRIMS	0.0025264880000000003	1.1476363267155945
LEGIUS SYNDROME	0.0025264880000000003	1.1476363267155945
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.0025264880000000003	1.1476363267155945
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0025264880000000003	1.1476363267155945
WARBURG MICRO SYNDROME 1	0.0025264880000000003	1.1476363267155945
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0025264880000000003	1.1476363267155945
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.0025264880000000003	1.1476363267155945
MOWAT-WILSON SYNDROME; MOWS	0.0025264880000000003	1.1476363267155945
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.002360138	1.0720732118505567
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.002360138	1.0720732118505567
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.002360138	1.0720732118505567
MARSHALL-SMITH SYNDROME; MRSHSS	0.002360138	1.0720732118505567
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.002360138	1.0720732118505567
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.002360138	1.0720732118505567
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.002360138	1.0720732118505567
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.002360138	1.0720732118505567
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002360138	1.0720732118505567
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.002360138	1.0720732118505567
COFFIN-SIRIS SYNDROME 10; CSS10	0.002360138	1.0720732118505567
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.002360138	1.0720732118505567
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.002360138	1.0720732118505567
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.002360138	1.0720732118505567
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.002360138	1.0720732118505567
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.002360138	1.0720732118505567
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.002360138	1.0720732118505567
GLUTAMINE DEFICIENCY, CONGENITAL	0.002360138	1.0720732118505567
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.002360138	1.0720732118505567
NON-DISTAL MONOSOMY 20Q	0.002360138	1.0720732118505567
NOONAN SYNDROME 7; NS7	0.002360138	1.0720732118505567
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.002360138	1.0720732118505567
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.002360138	1.0720732118505567
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.002360138	1.0720732118505567
PSEUDOTRISOMY 13 SYNDROME	0.002360138	1.0720732118505567
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.002360138	1.0720732118505567
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.002360138	1.0720732118505567
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.002360138	1.0720732118505567
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.002360138	1.0720732118505567
LISSENCEPHALY, X-LINKED, 2	0.002360138	1.0720732118505567
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.002360138	1.0720732118505567
JUVENILE POLYPOSIS OF INFANCY	0.002360138	1.0720732118505567
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.002360138	1.0720732118505567
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.002360138	1.0720732118505567
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.002110504	0.9586790272024125
NOONAN SYNDROME 9; NS9	0.002110504	0.9586790272024125
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.002110504	0.9586790272024125
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.002110504	0.9586790272024125
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.002110504	0.9586790272024125
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.002110504	0.9586790272024125
MONOSOMY 22Q13.3	0.002110504	0.9586790272024125
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.002110504	0.9586790272024125
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.002110504	0.9586790272024125
PALLISTER-HALL SYNDROME	0.002110504	0.9586790272024125
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.002110504	0.9586790272024125
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.002110504	0.9586790272024125
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.002110504	0.9586790272024125
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.002110504	0.9586790272024125
SMITH-LEMLI-OPITZ SYNDROME	0.002110504	0.9586790272024125
AARSKOG-SCOTT SYNDROME	0.002110504	0.9586790272024125
CHARGE SYNDROME	0.002110504	0.9586790272024125
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.002110504	0.9586790272024125
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.002110504	0.9586790272024125
HYPERTRICHOSIS CUBITI	0.002110504	0.9586790272024125
20Q11.2 MICRODUPLICATION SYNDROME	0.002110504	0.9586790272024125
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.002110504	0.9586790272024125
CODAS SYNDROME	0.002110504	0.9586790272024125
COFFIN-SIRIS SYNDROME	0.002110504	0.9586790272024125
JOUBERT SYNDROME WITH RENAL DEFECT	0.002110504	0.9586790272024125
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.002110504	0.9586790272024125
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.002110504	0.9586790272024125
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.002110504	0.9586790272024125
COFFIN-SIRIS SYNDROME 5	0.002110504	0.9586790272024125
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.002110504	0.9586790272024125
NOONAN SYNDROME 2; NS2	0.002110504	0.9586790272024125
JOUBERT SYNDROME WITH OCULAR DEFECT	0.002110504	0.9586790272024125
CDAGS SYNDROME	0.002110504	0.9586790272024125
OCULOFACIOCARDIODENTAL SYNDROME	0.002110504	0.9586790272024125
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.002110504	0.9586790272024125
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.002110504	0.9586790272024125
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.002110504	0.9586790272024125
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.002110504	0.9586790272024125
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.002110504	0.9586790272024125
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.002110504	0.9586790272024125
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.002110504	0.9586790272024125
WOLF-HIRSCHHORN SYNDROME	0.002110504	0.9586790272024125
MUENKE SYNDROME	0.002110504	0.9586790272024125
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.002110504	0.9586790272024125
POPOV-CHANG SYNDROME; POPCHAS	0.002110504	0.9586790272024125
RUVALCABA SYNDROME	0.002110504	0.9586790272024125
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.002110504	0.9586790272024125
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.002110504	0.9586790272024125
ISOLATED COMPLEX I DEFICIENCY	0.002110504	0.9586790272024125
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.002110504	0.9586790272024125
14Q22Q23 MICRODELETION SYNDROME	0.002110504	0.9586790272024125
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.002110504	0.9586790272024125
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.002110504	0.9586790272024125
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.002110504	0.9586790272024125
CORNELIA DE LANGE SYNDROME 3	0.002110504	0.9586790272024125
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.002110504	0.9586790272024125
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.002110504	0.9586790272024125
CHAR SYNDROME	0.002110504	0.9586790272024125
LATHOSTEROLOSIS	0.002110504	0.9586790272024125
PRADER-WILLI-LIKE SYNDROME	0.002110504	0.9586790272024125
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.002110504	0.9586790272024125
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.002110504	0.9586790272024125
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.002110504	0.9586790272024125
MONOSOMY 18P	0.002110504	0.9586790272024125
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.002110504	0.9586790272024125
FETAL HYDANTOIN SYNDROME	0.002110504	0.9586790272024125
FETAL ALCOHOL SYNDROME	0.002110504	0.9586790272024125
PHACE SYNDROME	0.002110504	0.9586790272024125
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.002110504	0.9586790272024125
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.002110504	0.9586790272024125
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.002110504	0.9586790272024125
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.002110504	0.9586790272024125
FRIAS SYNDROME	0.002110504	0.9586790272024125
BOHRING-OPITZ SYNDROME	0.0019441539999999998	0.8831159123373749
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.0019441539999999998	0.8831159123373749
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0019441539999999998	0.8831159123373749
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.0019441539999999998	0.8831159123373749
HARTSFIELD SYNDROME; HRTFDS	0.0019441539999999998	0.8831159123373749
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.0019441539999999998	0.8831159123373749
EAR-PATELLA-SHORT STATURE SYNDROME	0.0019441539999999998	0.8831159123373749
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.0019441539999999998	0.8831159123373749
15Q14 MICRODELETION SYNDROME	0.0019441539999999998	0.8831159123373749
16P13.11 MICRODELETION SYNDROME	0.0019441539999999998	0.8831159123373749
19P13.3 MICRODUPLICATION SYNDROME	0.0019441539999999998	0.8831159123373749
TEMTAMY SYNDROME	0.0019441539999999998	0.8831159123373749
BRESEK SYNDROME	0.0019441539999999998	0.8831159123373749
GENITOPATELLAR SYNDROME	0.0019441539999999998	0.8831159123373749
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0019441539999999998	0.8831159123373749
SWEENEY-COX SYNDROME; SWCOS	0.0019441539999999998	0.8831159123373749
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.0019441539999999998	0.8831159123373749
RAINE SYNDROME	0.0019441539999999998	0.8831159123373749
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.0019441539999999998	0.8831159123373749
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.0019441539999999998	0.8831159123373749
19P13.12 MICRODELETION SYNDROME	0.0019441539999999998	0.8831159123373749
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0019441539999999998	0.8831159123373749
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.0019441539999999998	0.8831159123373749
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.0019441539999999998	0.8831159123373749
TURNPENNY-FRY SYNDROME; TPFS	0.0019441539999999998	0.8831159123373749
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.0019441539999999998	0.8831159123373749
OTOPALATODIGITAL SYNDROME TYPE 2	0.0019441539999999998	0.8831159123373749
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.0019441539999999998	0.8831159123373749
WALKER-WARBURG SYNDROME	0.0019441539999999998	0.8831159123373749
2Q32Q33 MICRODELETION SYNDROME	0.0019441539999999998	0.8831159123373749
ALAZAMI SYNDROME; ALAZS	0.0019441539999999998	0.8831159123373749
3Q29 MICRODUPLICATION SYNDROME	0.0019441539999999998	0.8831159123373749
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0019441539999999998	0.8831159123373749
8P23.1 MICRODELETION SYNDROME	0.0019441539999999998	0.8831159123373749
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.0019441539999999998	0.8831159123373749
6Q16 MICRODELETION SYNDROME	0.0019441539999999998	0.8831159123373749
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.0019441539999999998	0.8831159123373749
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.0019441539999999998	0.8831159123373749
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.0019441539999999998	0.8831159123373749
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0019441539999999998	0.8831159123373749
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.0019441539999999998	0.8831159123373749
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.0019441539999999998	0.8831159123373749
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.0019441539999999998	0.8831159123373749
3C SYNDROME	0.0019441539999999998	0.8831159123373749
MONOSOMY 9Q22.3	0.0019441539999999998	0.8831159123373749
DIAMOND-BLACKFAN ANEMIA 5	0.0019441539999999998	0.8831159123373749
CATEL-MANZKE SYNDROME; CATMANS	0.0019441539999999998	0.8831159123373749
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.0019441539999999998	0.8831159123373749
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.0019441539999999998	0.8831159123373749
OGDEN SYNDROME; OGDNS	0.0019441539999999998	0.8831159123373749
CEREBELLOFACIODENTAL SYNDROME	0.0019441539999999998	0.8831159123373749
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.0019441539999999998	0.8831159123373749
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.0019441539999999998	0.8831159123373749
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0019441539999999998	0.8831159123373749
DE BARSY SYNDROME	0.0019441539999999998	0.8831159123373749
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0019441539999999998	0.8831159123373749
GLASS SYNDROME	0.0019441539999999998	0.8831159123373749
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.0019441539999999998	0.8831159123373749
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.0019441539999999998	0.8831159123373749
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.0019441539999999998	0.8831159123373749
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.0019441539999999998	0.8831159123373749
3Q29 MICRODELETION SYNDROME	0.0019441539999999998	0.8831159123373749
CHROMOSOME 15Q14 DELETION SYNDROME	0.0019441539999999998	0.8831159123373749
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0019441539999999998	0.8831159123373749
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0019441539999999998	0.8831159123373749
611961 STEVENSON-CAREY SYNDROME	0.0019441539999999998	0.8831159123373749
DOORS SYNDROME	0.0019441539999999998	0.8831159123373749
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.0019441539999999998	0.8831159123373749
BILATERAL POLYMICROGYRIA	0.0019441539999999998	0.8831159123373749
OPITZ G/BBB SYNDROME	0.0019441539999999998	0.8831159123373749
OROFACIODIGITAL SYNDROME TYPE 4	0.0019441539999999998	0.8831159123373749
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0019441539999999998	0.8831159123373749
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0019441539999999998	0.8831159123373749
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.0019441539999999998	0.8831159123373749
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0019441539999999998	0.8831159123373749
10Q22.3Q23.3 MICRODELETION SYNDROME	0.0019441539999999998	0.8831159123373749
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.0019441539999999998	0.8831159123373749
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0019441539999999998	0.8831159123373749
PHENOBARBITAL EMBRYOPATHY	0.0019441539999999998	0.8831159123373749
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0019441539999999998	0.8831159123373749
WRINKLY SKIN SYNDROME	0.0019441539999999998	0.8831159123373749
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.0019441539999999998	0.8831159123373749
MOSAIC TRISOMY 9	0.0019441539999999998	0.8831159123373749
PFEIFFER SYNDROME TYPE 2	0.0019441539999999998	0.8831159123373749
17P13.3 MICRODUPLICATION SYNDROME	0.0019441539999999998	0.8831159123373749
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.0019441539999999998	0.8831159123373749
ELSAHY-WATERS SYNDROME; ESWS	0.0019441539999999998	0.8831159123373749
AYMÃ‰-GRIPP SYNDROME	0.0019441539999999998	0.8831159123373749
NOONAN SYNDROME 3; NS3	0.0019441539999999998	0.8831159123373749
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.0019441539999999998	0.8831159123373749
TRISOMY 12P	0.0019441539999999998	0.8831159123373749
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.0019441539999999998	0.8831159123373749
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.0019441539999999998	0.8831159123373749
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.0019441539999999998	0.8831159123373749
RECOMBINANT 8 SYNDROME	0.0019441539999999998	0.8831159123373749
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0019441539999999998	0.8831159123373749
ICF SYNDROME	0.0019441539999999998	0.8831159123373749
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.0019441539999999998	0.8831159123373749
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.0019441539999999998	0.8831159123373749
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.0019441539999999998	0.8831159123373749
DISTAL MONOSOMY 6P	0.0019441539999999998	0.8831159123373749
FORSYTHE-WAKELING SYNDROME; FWS	0.0019441539999999998	0.8831159123373749
DISTAL MONOSOMY 1Q	0.0019441539999999998	0.8831159123373749
HOLMES-GANG SYNDROME	0.0019441539999999998	0.8831159123373749
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.0019441539999999998	0.8831159123373749
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.0019441539999999998	0.8831159123373749
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.0019441539999999998	0.8831159123373749
19P13.13 MICRODELETION SYNDROME	0.0019441539999999998	0.8831159123373749
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00156495	0.7108656243344791
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.00156495	0.7108656243344791
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00156495	0.7108656243344791
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00156495	0.7108656243344791
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00156495	0.7108656243344791
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00156495	0.7108656243344791
PACHYDERMOPERIOSTOSIS	0.00156495	0.7108656243344791
WERNICKE-KORSAKOFF SYNDROME	0.00156495	0.7108656243344791
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00156495	0.7108656243344791
BRANCHIO-OCULO-FACIAL SYNDROME	0.00156495	0.7108656243344791
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00156495	0.7108656243344791
JACKSON-WEISS SYNDROME	0.00156495	0.7108656243344791
OCULOCEREBROCUTANEOUS SYNDROME	0.00156495	0.7108656243344791
KAWASAKI DISEASE	0.00156495	0.7108656243344791
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00156495	0.7108656243344791
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00156495	0.7108656243344791
KEIPERT SYNDROME	0.00156495	0.7108656243344791
HARTSFIELD SYNDROME	0.00156495	0.7108656243344791
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00156495	0.7108656243344791
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00156495	0.7108656243344791
OCULOPHARYNGEAL MUSCULAR DYSTROPHY	0.00156495	0.7108656243344791
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00156495	0.7108656243344791
PROTEUS SYNDROME	0.00156495	0.7108656243344791
REFSUM DISEASE	0.00156495	0.7108656243344791
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.00156495	0.7108656243344791
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.00156495	0.7108656243344791
DERMOODONTODYSPLASIA	0.00156495	0.7108656243344791
PROGRESSIVE HEMIFACIAL ATROPHY	0.00156495	0.7108656243344791
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.00156495	0.7108656243344791
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.00156495	0.7108656243344791
MACHADO-JOSEPH DISEASE; MJD	0.00156495	0.7108656243344791
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.00156495	0.7108656243344791
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.00156495	0.7108656243344791
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.00156495	0.7108656243344791
POSTERIOR FUSION OF LUMBOSACRAL VERTEBRAE-BLEPHAROPTOSIS SYNDROME	0.00156495	0.7108656243344791
SPINOCEREBELLAR ATAXIA TYPE 36	0.00156495	0.7108656243344791
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.00156495	0.7108656243344791
%300245 PTOSIS, HEREDITARY CONGENITAL 2;;PTOS2;;PTOSIS, X-LINKED; PTOSX	0.00156495	0.7108656243344791
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00156495	0.7108656243344791
RHYNS SYNDROME	0.00156495	0.7108656243344791
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00156495	0.7108656243344791
NOONAN SYNDROME	0.00156495	0.7108656243344791
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00156495	0.7108656243344791
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00156495	0.7108656243344791
NOONAN SYNDROME 10; NS10	0.00156495	0.7108656243344791
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00156495	0.7108656243344791
PROLACTINOMA	0.00156495	0.7108656243344791
2P15-16.1 MICRODELETION SYNDROME	0.00156495	0.7108656243344791
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00156495	0.7108656243344791
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.00156495	0.7108656243344791
DEAFNESS, X-LINKED 7; DFNX7	0.00156495	0.7108656243344791
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.00156495	0.7108656243344791
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.00156495	0.7108656243344791
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00156495	0.7108656243344791
ACROCRANIOFACIAL DYSOSTOSIS	0.00156495	0.7108656243344791
RING CHROMOSOME 1 SYNDROME	0.00156495	0.7108656243344791
X-LINKED CENTRONUCLEAR MYOPATHY	0.00156495	0.7108656243344791
CENTRONUCLEAR MYOPATHY	0.00156495	0.7108656243344791
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00156495	0.7108656243344791
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00156495	0.7108656243344791
THYMOMA	0.00156495	0.7108656243344791
MALIGNANT ATROPHIC PAPULOSIS	0.00156495	0.7108656243344791
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00156495	0.7108656243344791
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00156495	0.7108656243344791
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00156495	0.7108656243344791
OPHTHALMOPLEGIA, FAMILIAL STATIC	0.00156495	0.7108656243344791
CAREY-FINEMAN-ZITER SYNDROME	0.00156495	0.7108656243344791
REFSUM DISEASE	0.00156495	0.7108656243344791
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00156495	0.7108656243344791
DILATED CARDIOMYOPATHY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.00156495	0.7108656243344791
PURPURA SIMPLEX	0.00156495	0.7108656243344791
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.00156495	0.7108656243344791
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00156495	0.7108656243344791
FREEMAN-SHELDON SYNDROME	0.00156495	0.7108656243344791
PFEIFFER SYNDROME	0.00156495	0.7108656243344791
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.00156495	0.7108656243344791
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00156495	0.7108656243344791
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.00156495	0.7108656243344791
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00156495	0.7108656243344791
BULBAR PALSY, PROGRESSIVE, OF CHILDHOOD	0.00156495	0.7108656243344791
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00156495	0.7108656243344791
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00156495	0.7108656243344791
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00156495	0.7108656243344791
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.00156495	0.7108656243344791
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.00156495	0.7108656243344791
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00156495	0.7108656243344791
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00156495	0.7108656243344791
WAARDENBURG SYNDROME TYPE 2	0.00156495	0.7108656243344791
WAARDENBURG SYNDROME TYPE 1	0.00156495	0.7108656243344791
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.00156495	0.7108656243344791
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00156495	0.7108656243344791
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00156495	0.7108656243344791
TRISOMY 5P	0.00156495	0.7108656243344791
AASE-SMITH SYNDROME I	0.00156495	0.7108656243344791
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00156495	0.7108656243344791
WAGR SYNDROME	0.00156495	0.7108656243344791
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00156495	0.7108656243344791
PAROXYSMAL HEMICRANIA	0.00156495	0.7108656243344791
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00156495	0.7108656243344791
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00156495	0.7108656243344791
INHALATIONAL BOTULISM	0.00156495	0.7108656243344791
IATROGENIC BOTULISM	0.00156495	0.7108656243344791
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.00156495	0.7108656243344791
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00156495	0.7108656243344791
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00156495	0.7108656243344791
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00156495	0.7108656243344791
TYPICAL NEMALINE MYOPATHY	0.00156495	0.7108656243344791
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00156495	0.7108656243344791
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00156495	0.7108656243344791
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00156495	0.7108656243344791
NAGER SYNDROME	0.00156495	0.7108656243344791
HOLOPROSENCEPHALY 4	0.00156495	0.7108656243344791
ISOLATED CONGENITAL ALACRIMA	0.00156495	0.7108656243344791
NON-FUNCTIONING PITUITARY ADENOMA	0.00156495	0.7108656243344791
TSH-SECRETING PITUITARY ADENOMA	0.00156495	0.7108656243344791
VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB	0.00156495	0.7108656243344791
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00156495	0.7108656243344791
KABUKI SYNDROME	0.00156495	0.7108656243344791
HYPERTELORISM, TEEBI TYPE; TBHS	0.00156495	0.7108656243344791
MESOMELIA-SYNOSTOSES SYNDROME	0.00156495	0.7108656243344791
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.00156495	0.7108656243344791
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00156495	0.7108656243344791
JUBERG-HAYWARD SYNDROME	0.00156495	0.7108656243344791
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00156495	0.7108656243344791
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT	0.00156495	0.7108656243344791
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00156495	0.7108656243344791
MCDONOUGH SYNDROME	0.00156495	0.7108656243344791
GOOD SYNDROME	0.00156495	0.7108656243344791
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00156495	0.7108656243344791
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.00156495	0.7108656243344791
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00156495	0.7108656243344791
PITUITARY APOPLEXY	0.00156495	0.7108656243344791
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00156495	0.7108656243344791
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00156495	0.7108656243344791
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.00156495	0.7108656243344791
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00156495	0.7108656243344791
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00156495	0.7108656243344791
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00156495	0.7108656243344791
OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA	0.00156495	0.7108656243344791
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00156495	0.7108656243344791
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00156495	0.7108656243344791
MACROSTOMIA-PREAURICULAR TAGS-EXTERNAL OPHTHALMOPLEGIA SYNDROME	0.00156495	0.7108656243344791
CROUZON DISEASE	0.00156495	0.7108656243344791
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00156495	0.7108656243344791
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.00156495	0.7108656243344791
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00156495	0.7108656243344791
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00156495	0.7108656243344791
OCULOGASTROINTESTINAL MUSCULAR DYSTROPHY	0.00156495	0.7108656243344791
FOODBORNE BOTULISM	0.00156495	0.7108656243344791
SPINOCEREBELLAR ATAXIA TYPE 28	0.00156495	0.7108656243344791
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00156495	0.7108656243344791
THYMIC TUMOR	0.00156495	0.7108656243344791
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00156495	0.7108656243344791
NON-DISTAL MONOSOMY 10Q	0.00156495	0.7108656243344791
ACROCRANIOFACIAL DYSOSTOSIS	0.00156495	0.7108656243344791
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.00156495	0.7108656243344791
WOUND BOTULISM	0.00156495	0.7108656243344791
INFANT BOTULISM	0.00156495	0.7108656243344791
INTESTINAL BOTULISM	0.00156495	0.7108656243344791
ADULT INTESTINAL BOTULISM	0.00156495	0.7108656243344791
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.00156495	0.7108656243344791
MYASTHENIA GRAVIS; MG	0.00156495	0.7108656243344791
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.00156495	0.7108656243344791
CLUSTER HEADACHE, FAMILIAL	0.00156495	0.7108656243344791
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.00156495	0.7108656243344791
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00156495	0.7108656243344791
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00156495	0.7108656243344791
CHARGE SYNDROME	0.00156495	0.7108656243344791
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00156495	0.7108656243344791
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.00156495	0.7108656243344791
TETRASOMY 12P	0.00156495	0.7108656243344791
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00156495	0.7108656243344791
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	0.00156495	0.7108656243344791
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.00156495	0.7108656243344791
MELAS	0.00156495	0.7108656243344791
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00156495	0.7108656243344791
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.00156495	0.7108656243344791
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00156495	0.7108656243344791
THYMIC EPITHELIAL NEOPLASM	0.00156495	0.7108656243344791
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.00156495	0.7108656243344791
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00156495	0.7108656243344791
KALLMANN SYNDROME	0.00156495	0.7108656243344791
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.00156495	0.7108656243344791
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.00156495	0.7108656243344791
MECKEL SYNDROME, TYPE 10; MKS10	0.00156495	0.7108656243344791
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00156495	0.7108656243344791
TUKEL SYNDROME	0.00156495	0.7108656243344791
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00156495	0.7108656243344791
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.00156495	0.7108656243344791
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00156495	0.7108656243344791
FRONTORHINY	0.00156495	0.7108656243344791
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00156495	0.7108656243344791
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5; CFEOM5	0.00156495	0.7108656243344791
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.00156495	0.7108656243344791
GIANT CELL ARTERITIS	0.00156495	0.7108656243344791
FOUNTAIN SYNDROME	0.00156495	0.7108656243344791
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00156495	0.7108656243344791
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00156495	0.7108656243344791
KEARNS-SAYRE SYNDROME; KSS	0.00156495	0.7108656243344791
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00156495	0.7108656243344791
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00156495	0.7108656243344791
CHIME SYNDROME	0.00156495	0.7108656243344791
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00156495	0.7108656243344791
WAARDENBURG SYNDROME	0.00156495	0.7108656243344791
MESOMELIA-SYNOSTOSES SYNDROME	0.00156495	0.7108656243344791
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00156495	0.7108656243344791
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00156495	0.7108656243344791
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00156495	0.7108656243344791
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00156495	0.7108656243344791
17Q24.2 MICRODELETION SYNDROME	0.00156495	0.7108656243344791
SCLEROSTEOSIS	0.00156495	0.7108656243344791
SIX2-RELATED FRONTONASAL DYSPLASIA	0.00156495	0.7108656243344791
608028 THAI SYMPHALANGISM SYNDROME	0.00156495	0.7108656243344791
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.00156495	0.7108656243344791
SCARF SYNDROME	0.00156495	0.7108656243344791
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00156495	0.7108656243344791
9Q21.13 MICRODELETION SYNDROME	0.00156495	0.7108656243344791
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00156495	0.7108656243344791
ERDHEIM-CHESTER DISEASE	0.00156495	0.7108656243344791
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00156495	0.7108656243344791
MUCOPOLYSACCHARIDOSIS, TYPE II	0.00156495	0.7108656243344791
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00156495	0.7108656243344791
LOEYS-DIETZ SYNDROME 5	0.00156495	0.7108656243344791
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00156495	0.7108656243344791
MYASTHENIA GRAVIS	0.00156495	0.7108656243344791
ALEXANDER DISEASE	0.00156495	0.7108656243344791
FACIOCARDIOMELIC SYNDROME	0.00156495	0.7108656243344791
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00156495	0.7108656243344791
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00156495	0.7108656243344791
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00156495	0.7108656243344791
MOEBIUS SYNDROME	0.00156495	0.7108656243344791
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00156495	0.7108656243344791
NOONAN SYNDROME 4; NS4	0.00156495	0.7108656243344791
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00156495	0.7108656243344791
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00156495	0.7108656243344791
RHYNS SYNDROME; RHYNS	0.00156495	0.7108656243344791
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.00156495	0.7108656243344791
NEONATAL ADRENOLEUKODYSTROPHY	0.00156495	0.7108656243344791
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00156495	0.7108656243344791
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00156495	0.7108656243344791
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.00156495	0.7108656243344791
ALLAN-HERNDON-DUDLEY SYNDROME	0.00156495	0.7108656243344791
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.00156495	0.7108656243344791
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.00156495	0.7108656243344791
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00156495	0.7108656243344791
SALIH MYOPATHY; SALMY	0.00156495	0.7108656243344791
CENANI-LENZ SYNDROME	0.00156495	0.7108656243344791
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.001507092	0.6845841052490487
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001507092	0.6845841052490487
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001507092	0.6845841052490487
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001507092	0.6845841052490487
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001507092	0.6845841052490487
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.001507092	0.6845841052490487
GENITOPATELLAR SYNDROME; GTPTS	0.001507092	0.6845841052490487
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.001507092	0.6845841052490487
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001507092	0.6845841052490487
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.001507092	0.6845841052490487
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001507092	0.6845841052490487
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001507092	0.6845841052490487
HYPERPROLINEMIA, TYPE I	0.001507092	0.6845841052490487
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.001507092	0.6845841052490487
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.001507092	0.6845841052490487
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001507092	0.6845841052490487
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001507092	0.6845841052490487
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001507092	0.6845841052490487
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.001507092	0.6845841052490487
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001507092	0.6845841052490487
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001507092	0.6845841052490487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.001507092	0.6845841052490487
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.001507092	0.6845841052490487
COFFIN-SIRIS SYNDROME 6; CSS6	0.001507092	0.6845841052490487
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001507092	0.6845841052490487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001507092	0.6845841052490487
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001507092	0.6845841052490487
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001507092	0.6845841052490487
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.001507092	0.6845841052490487
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001507092	0.6845841052490487
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.001507092	0.6845841052490487
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.001507092	0.6845841052490487
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001507092	0.6845841052490487
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001507092	0.6845841052490487
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.001507092	0.6845841052490487
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.001507092	0.6845841052490487
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001507092	0.6845841052490487
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001507092	0.6845841052490487
HOLOPROSENCEPHALY 1; HPE1	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.001507092	0.6845841052490487
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001507092	0.6845841052490487
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001507092	0.6845841052490487
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001507092	0.6845841052490487
MARINESCO-SJOGREN SYNDROME; MSS	0.001507092	0.6845841052490487
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001507092	0.6845841052490487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.001507092	0.6845841052490487
TRICHOTHIODYSTROPHY	0.001507092	0.6845841052490487
TETRASOMY 9P	0.001507092	0.6845841052490487
METHYLMALONIC ACIDURIA, CBLB TYPE	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.001507092	0.6845841052490487
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.001507092	0.6845841052490487
SIALIDOSIS TYPE 2	0.001507092	0.6845841052490487
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.001507092	0.6845841052490487
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001507092	0.6845841052490487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001507092	0.6845841052490487
INFANTILE LIVER FAILURE SYNDROME 1	0.001507092	0.6845841052490487
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001507092	0.6845841052490487
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.001507092	0.6845841052490487
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001507092	0.6845841052490487
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001507092	0.6845841052490487
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001507092	0.6845841052490487
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001507092	0.6845841052490487
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001507092	0.6845841052490487
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001507092	0.6845841052490487
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001507092	0.6845841052490487
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.001507092	0.6845841052490487
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.001507092	0.6845841052490487
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001507092	0.6845841052490487
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001507092	0.6845841052490487
KETOADIPICACIDURIA	0.001507092	0.6845841052490487
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.001507092	0.6845841052490487
CK SYNDROME	0.001507092	0.6845841052490487
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001507092	0.6845841052490487
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001507092	0.6845841052490487
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.001507092	0.6845841052490487
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.001507092	0.6845841052490487
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.001507092	0.6845841052490487
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001507092	0.6845841052490487
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001507092	0.6845841052490487
8Q24.3 MICRODELETION SYNDROME	0.001507092	0.6845841052490487
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001507092	0.6845841052490487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001507092	0.6845841052490487
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001507092	0.6845841052490487
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.001507092	0.6845841052490487
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001507092	0.6845841052490487
GALACTOSE EPIMERASE DEFICIENCY	0.001507092	0.6845841052490487
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001507092	0.6845841052490487
FUMARASE DEFICIENCY; FMRD	0.001507092	0.6845841052490487
STT3B-CDG	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001507092	0.6845841052490487
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001507092	0.6845841052490487
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.001507092	0.6845841052490487
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001507092	0.6845841052490487
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001507092	0.6845841052490487
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.001507092	0.6845841052490487
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001507092	0.6845841052490487
RIGID SPINE SYNDROME	0.001507092	0.6845841052490487
SALT-AND-PEPPER SYNDROME	0.001507092	0.6845841052490487
PRADER-WILLI SYNDROME; PWS	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001507092	0.6845841052490487
SSR4-CDG	0.001507092	0.6845841052490487
STT3A-CDG	0.001507092	0.6845841052490487
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001507092	0.6845841052490487
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.001507092	0.6845841052490487
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.001507092	0.6845841052490487
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001507092	0.6845841052490487
SCHINDLER DISEASE, TYPE I	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001507092	0.6845841052490487
SMITH-MAGENIS SYNDROME; SMS	0.001507092	0.6845841052490487
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.001507092	0.6845841052490487
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.001507092	0.6845841052490487
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001507092	0.6845841052490487
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.001507092	0.6845841052490487
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001507092	0.6845841052490487
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.001507092	0.6845841052490487
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001507092	0.6845841052490487
FOLATE MALABSORPTION, HEREDITARY	0.001507092	0.6845841052490487
POTOCKI-LUPSKI SYNDROME	0.001507092	0.6845841052490487
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001507092	0.6845841052490487
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001507092	0.6845841052490487
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.001507092	0.6845841052490487
ADAMS-OLIVER SYNDROME 1; AOS1	0.001507092	0.6845841052490487
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001507092	0.6845841052490487
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001507092	0.6845841052490487
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001507092	0.6845841052490487
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.001507092	0.6845841052490487
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001507092	0.6845841052490487
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001507092	0.6845841052490487
SPINOCEREBELLAR ATAXIA TYPE 29	0.001507092	0.6845841052490487
HOLOPROSENCEPHALY 2; HPE2	0.001507092	0.6845841052490487
WARSAW BREAKAGE SYNDROME; WABS	0.001507092	0.6845841052490487
JOUBERT SYNDROME 6	0.001507092	0.6845841052490487
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.001507092	0.6845841052490487
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.001507092	0.6845841052490487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001507092	0.6845841052490487
CHROMOSOME 4Q21 DELETION SYNDROME	0.001507092	0.6845841052490487
SPINOCEREBELLAR ATAXIA TYPE 13	0.001507092	0.6845841052490487
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.001507092	0.6845841052490487
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001507092	0.6845841052490487
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.001507092	0.6845841052490487
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.001507092	0.6845841052490487
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.001507092	0.6845841052490487
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001507092	0.6845841052490487
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.001507092	0.6845841052490487
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.001507092	0.6845841052490487
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001507092	0.6845841052490487
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001507092	0.6845841052490487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001507092	0.6845841052490487
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.001507092	0.6845841052490487
CEREBELLAR ATAXIA, CAYMAN TYPE	0.001507092	0.6845841052490487
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001507092	0.6845841052490487
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.001507092	0.6845841052490487
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001507092	0.6845841052490487
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001507092	0.6845841052490487
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001507092	0.6845841052490487
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.001507092	0.6845841052490487
NIEMANN-PICK DISEASE, TYPE C2	0.001507092	0.6845841052490487
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.001507092	0.6845841052490487
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001507092	0.6845841052490487
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001507092	0.6845841052490487
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001507092	0.6845841052490487
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001507092	0.6845841052490487
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.001507092	0.6845841052490487
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.001507092	0.6845841052490487
PEROXISOME BIOGENESIS DISORDER 5B	0.001507092	0.6845841052490487
PEROXISOME BIOGENESIS DISORDER 6B	0.001507092	0.6845841052490487
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001507092	0.6845841052490487
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.001507092	0.6845841052490487
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001507092	0.6845841052490487
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001507092	0.6845841052490487
GRISCELLI SYNDROME, TYPE 1	0.001507092	0.6845841052490487
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.001507092	0.6845841052490487
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001507092	0.6845841052490487
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001507092	0.6845841052490487
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.001507092	0.6845841052490487
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001507092	0.6845841052490487
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001507092	0.6845841052490487
MICROPHTHALMIA, SYNDROMIC 3	0.001507092	0.6845841052490487
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001507092	0.6845841052490487
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001507092	0.6845841052490487
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001507092	0.6845841052490487
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001507092	0.6845841052490487
JOUBERT SYNDROME 15	0.001507092	0.6845841052490487
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001507092	0.6845841052490487
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001507092	0.6845841052490487
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.001507092	0.6845841052490487
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001507092	0.6845841052490487
PERIPHERAL HYPOTHYROIDISM	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.001507092	0.6845841052490487
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.001507092	0.6845841052490487
COFFIN-SIRIS SYNDROME 2; CSS2	0.001507092	0.6845841052490487
COFFIN-SIRIS SYNDROME 3; CSS3	0.001507092	0.6845841052490487
COFFIN-SIRIS SYNDROME 4; CSS4	0.001507092	0.6845841052490487
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001507092	0.6845841052490487
MUCOLIPIDOSIS IV; ML4	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.001507092	0.6845841052490487
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.001507092	0.6845841052490487
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.001507092	0.6845841052490487
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001507092	0.6845841052490487
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.001507092	0.6845841052490487
WEAVER SYNDROME	0.001507092	0.6845841052490487
JOUBERT SYNDROME 8	0.001507092	0.6845841052490487
JOUBERT SYNDROME 27	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.001507092	0.6845841052490487
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001507092	0.6845841052490487
SPINOCEREBELLAR ATAXIA 5; SCA5	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.001507092	0.6845841052490487
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001507092	0.6845841052490487
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001507092	0.6845841052490487
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.001507092	0.6845841052490487
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001507092	0.6845841052490487
MEHMO SYNDROME; MEHMO	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001507092	0.6845841052490487
YOU-HOOVER-FONG SYNDROME; YHFS	0.001507092	0.6845841052490487
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001507092	0.6845841052490487
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001507092	0.6845841052490487
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.001507092	0.6845841052490487
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.001507092	0.6845841052490487
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.001507092	0.6845841052490487
PEROXISOME BIOGENESIS DISORDER 3B	0.001507092	0.6845841052490487
AICARDI-GOUTIERES SYNDROME 7	0.001507092	0.6845841052490487
OPTIC ATROPHY 11; OPA11	0.001507092	0.6845841052490487
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.001507092	0.6845841052490487
OROFACIODIGITAL SYNDROME TYPE 6	0.001507092	0.6845841052490487
TIMOTHY SYNDROME; TS	0.001507092	0.6845841052490487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001507092	0.6845841052490487
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001507092	0.6845841052490487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.001507092	0.6845841052490487
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.001507092	0.6845841052490487
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.001507092	0.6845841052490487
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001507092	0.6845841052490487
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001507092	0.6845841052490487
SULFOCYSTEINURIA	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.001507092	0.6845841052490487
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.001507092	0.6845841052490487
HAREL-YOON SYNDROME; HAYOS	0.001507092	0.6845841052490487
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.001507092	0.6845841052490487
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001507092	0.6845841052490487
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.001507092	0.6845841052490487
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.001507092	0.6845841052490487
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001507092	0.6845841052490487
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001507092	0.6845841052490487
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.001507092	0.6845841052490487
MENTAL RETARDATION, X-LINKED 99	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001507092	0.6845841052490487
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.001507092	0.6845841052490487
TONNE-KALSCHEUER SYNDROME; TOKAS	0.001507092	0.6845841052490487
XQ25 DUPLICATION SYNDROME	0.001507092	0.6845841052490487
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001507092	0.6845841052490487
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.001507092	0.6845841052490487
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001507092	0.6845841052490487
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.001507092	0.6845841052490487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.001507092	0.6845841052490487
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.001507092	0.6845841052490487
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.001507092	0.6845841052490487
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001507092	0.6845841052490487
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.001507092	0.6845841052490487
SHUKLA-VERNON SYNDROME; SHUVER	0.001507092	0.6845841052490487
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001507092	0.6845841052490487
CRANIOFRONTONASAL SYNDROME; CFNS	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001507092	0.6845841052490487
PETTIGREW SYNDROME	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001507092	0.6845841052490487
JOUBERT SYNDROME 24	0.001507092	0.6845841052490487
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001507092	0.6845841052490487
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001507092	0.6845841052490487
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001507092	0.6845841052490487
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001507092	0.6845841052490487
LUSCAN-LUMISH SYNDROME; LLS	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.001507092	0.6845841052490487
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001507092	0.6845841052490487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001507092	0.6845841052490487
PELIZAEUS-MERZBACHER DISEASE	0.001507092	0.6845841052490487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.001507092	0.6845841052490487
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.001507092	0.6845841052490487
JOUBERT SYNDROME 25	0.001507092	0.6845841052490487
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001507092	0.6845841052490487
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.001507092	0.6845841052490487
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.001507092	0.6845841052490487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001507092	0.6845841052490487
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.001507092	0.6845841052490487
MENTAL RETARDATION, X-LINKED 41	0.001507092	0.6845841052490487
MENTAL RETARDATION, X-LINKED 90	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001507092	0.6845841052490487
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001507092	0.6845841052490487
DESANTO-SHINAWI SYNDROME	0.001507092	0.6845841052490487
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.001507092	0.6845841052490487
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001507092	0.6845841052490487
PYRUVATE CARBOXYLASE DEFICIENCY	0.001507092	0.6845841052490487
JOUBERT SYNDROME 28	0.001507092	0.6845841052490487
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001507092	0.6845841052490487
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.001507092	0.6845841052490487
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001507092	0.6845841052490487
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001507092	0.6845841052490487
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.001507092	0.6845841052490487
SHWACHMAN-DIAMOND SYNDROME	0.001507092	0.6845841052490487
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001507092	0.6845841052490487
NIEMANN-PICK DISEASE, TYPE A	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001507092	0.6845841052490487
XQ25 MICRODUPLICATION SYNDROME	0.001507092	0.6845841052490487
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001507092	0.6845841052490487
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001507092	0.6845841052490487
GRISCELLI SYNDROME TYPE 1	0.001507092	0.6845841052490487
NAVAJO NEUROHEPATOPATHY	0.001507092	0.6845841052490487
IMMUNODEFICIENCY 23; IMD23	0.001507092	0.6845841052490487
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001507092	0.6845841052490487
JOUBERT SYNDROME 31; JBTS31	0.001507092	0.6845841052490487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001507092	0.6845841052490487
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.001507092	0.6845841052490487
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001507092	0.6845841052490487
JOUBERT SYNDROME 32; JBTS32	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001507092	0.6845841052490487
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001507092	0.6845841052490487
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001507092	0.6845841052490487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001507092	0.6845841052490487
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001507092	0.6845841052490487
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.001507092	0.6845841052490487
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001507092	0.6845841052490487
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001507092	0.6845841052490487
EPILEPSY, PYRIDOXINE-DEPENDENT	0.001507092	0.6845841052490487
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001507092	0.6845841052490487
ELEJALDE DISEASE	0.001507092	0.6845841052490487
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001507092	0.6845841052490487
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001507092	0.6845841052490487
DESBUQUOIS DYSPLASIA 2; DBQD2	0.001507092	0.6845841052490487
PEHO SYNDROME; PEHO	0.001507092	0.6845841052490487
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001507092	0.6845841052490487
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001507092	0.6845841052490487
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001507092	0.6845841052490487
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.0013985999999999998	0.6353025094694414
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.0013985999999999998	0.6353025094694414
OROFACIODIGITAL SYNDROME XVII	0.0013985999999999998	0.6353025094694414
SECKEL SYNDROME 4	0.0013985999999999998	0.6353025094694414
IMAGE SYNDROME	0.0013985999999999998	0.6353025094694414
OROFACIODIGITAL SYNDROME I; OFD1	0.0013985999999999998	0.6353025094694414
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.0013985999999999998	0.6353025094694414
HENNEKAM SYNDROME	0.0013985999999999998	0.6353025094694414
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.0013985999999999998	0.6353025094694414
SLC39A8-CDG	0.0013985999999999998	0.6353025094694414
MEIER-GORLIN SYNDROME 3; MGORS3	0.0013985999999999998	0.6353025094694414
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.0013985999999999998	0.6353025094694414
OROFACIODIGITAL SYNDROME III	0.0013985999999999998	0.6353025094694414
CAMPOMELIC DYSPLASIA	0.0013985999999999998	0.6353025094694414
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0013985999999999998	0.6353025094694414
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.0013985999999999998	0.6353025094694414
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.0013985999999999998	0.6353025094694414
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.0013985999999999998	0.6353025094694414
ACRORENAL-MANDIBULAR SYNDROME	0.0013985999999999998	0.6353025094694414
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.0013985999999999998	0.6353025094694414
RING CHROMOSOME 10 SYNDROME	0.0013985999999999998	0.6353025094694414
MECKEL SYNDROME, TYPE 1; MKS1	0.0013985999999999998	0.6353025094694414
OROFACIAL CLEFT 15	0.0013985999999999998	0.6353025094694414
MEIER-GORLIN SYNDROME 5; MGORS5	0.0013985999999999998	0.6353025094694414
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.0013985999999999998	0.6353025094694414
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.0013985999999999998	0.6353025094694414
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.0013985999999999998	0.6353025094694414
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.0013985999999999998	0.6353025094694414
CRANIOFACIAL DYSSYNOSTOSIS	0.0013985999999999998	0.6353025094694414
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.0013985999999999998	0.6353025094694414
GÃ“MEZ-LÃ“PEZ-HERNÃNDEZ SYNDROME	0.0013985999999999998	0.6353025094694414
TRISOMY 1Q	0.0013985999999999998	0.6353025094694414
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.0013985999999999998	0.6353025094694414
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.0013985999999999998	0.6353025094694414
3Q27.3 MICRODELETION SYNDROME	0.0013985999999999998	0.6353025094694414
HYDROLETHALUS SYNDROME 1	0.0013985999999999998	0.6353025094694414
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.0013985999999999998	0.6353025094694414
HAMAMY SYNDROME; HMMS	0.0013985999999999998	0.6353025094694414
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.0013985999999999998	0.6353025094694414
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.0013985999999999998	0.6353025094694414
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.0013985999999999998	0.6353025094694414
RENAL AGENESIS, BILATERAL	0.0013985999999999998	0.6353025094694414
CONO-SPONDYLAR DYSPLASIA	0.0013985999999999998	0.6353025094694414
INIENCEPHALY	0.0013985999999999998	0.6353025094694414
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0013985999999999998	0.6353025094694414
EDINBURGH MALFORMATION SYNDROME	0.0013985999999999998	0.6353025094694414
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.0013985999999999998	0.6353025094694414
HYPOGLOSSIA WITH SITUS INVERSUS	0.0013985999999999998	0.6353025094694414
PYKNOACHONDROGENESIS	0.0013985999999999998	0.6353025094694414
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.0013985999999999998	0.6353025094694414
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.0013985999999999998	0.6353025094694414
GAPO SYNDROME	0.0013985999999999998	0.6353025094694414
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.0013985999999999998	0.6353025094694414
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.0013985999999999998	0.6353025094694414
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.0013985999999999998	0.6353025094694414
OTOFACIOCERVICAL SYNDROME 2	0.0013985999999999998	0.6353025094694414
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.0013985999999999998	0.6353025094694414
FEMORAL-FACIAL SYNDROME	0.0013985999999999998	0.6353025094694414
15Q26 OVERGROWTH SYNDROME	0.0013985999999999998	0.6353025094694414
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.0013985999999999998	0.6353025094694414
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.0013985999999999998	0.6353025094694414
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.0013985999999999998	0.6353025094694414
ACROCARDIOFACIAL SYNDROME	0.0013985999999999998	0.6353025094694414
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0013985999999999998	0.6353025094694414
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.0013985999999999998	0.6353025094694414
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.0013985999999999998	0.6353025094694414
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.0013985999999999998	0.6353025094694414
PERMANENT NEONATAL DIABETES MELLITUS-PANCREATIC AND CEREBELLAR AGENESIS SYNDROME	0.0013985999999999998	0.6353025094694414
FOCAL DERMAL HYPOPLASIA	0.0013985999999999998	0.6353025094694414
FIBROCHONDROGENESIS	0.0013985999999999998	0.6353025094694414
ATELOSTEOGENESIS TYPE II	0.0013985999999999998	0.6353025094694414
MECKEL SYNDROME 12; MKS12	0.0013985999999999998	0.6353025094694414
MOSAIC TRISOMY 1	0.0013985999999999998	0.6353025094694414
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.0013985999999999998	0.6353025094694414
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0013985999999999998	0.6353025094694414
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.0013985999999999998	0.6353025094694414
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.0013985999999999998	0.6353025094694414
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0013985999999999998	0.6353025094694414
FOCAL FACIAL DERMAL DYSPLASIA TYPE II	0.0013985999999999998	0.6353025094694414
DIAMOND-BLACKFAN ANEMIA 10	0.0013985999999999998	0.6353025094694414
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.0013985999999999998	0.6353025094694414
SPONDYLO-OCULAR SYNDROME	0.0013985999999999998	0.6353025094694414
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.0013985999999999998	0.6353025094694414
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.0013985999999999998	0.6353025094694414
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.0013985999999999998	0.6353025094694414
GENITOPALATOCARDIAC SYNDROME	0.0013985999999999998	0.6353025094694414
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.0013985999999999998	0.6353025094694414
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.0013985999999999998	0.6353025094694414
KEIPERT SYNDROME; KPTS	0.0013985999999999998	0.6353025094694414
ADNP SYNDROME	0.0013985999999999998	0.6353025094694414
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.0013985999999999998	0.6353025094694414
NEMALINE MYOPATHY 2; NEM2	0.0013985999999999998	0.6353025094694414
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.0013985999999999998	0.6353025094694414
TETRAAMELIA SYNDROME 2; TETAMS2	0.0013985999999999998	0.6353025094694414
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.0013985999999999998	0.6353025094694414
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.0013985999999999998	0.6353025094694414
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.0013985999999999998	0.6353025094694414
KAPUR-TORIELLO SYNDROME	0.0013985999999999998	0.6353025094694414
SCHINZEL-GIEDION SYNDROME	0.0013985999999999998	0.6353025094694414
47,XYY SYNDROME	0.0013985999999999998	0.6353025094694414
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0013985999999999998	0.6353025094694414
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.0013985999999999998	0.6353025094694414
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.0013985999999999998	0.6353025094694414
THANATOPHORIC DYSPLASIA	0.0013985999999999998	0.6353025094694414
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.0013985999999999998	0.6353025094694414
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.0013985999999999998	0.6353025094694414
TRANSALDOLASE DEFICIENCY	0.0013985999999999998	0.6353025094694414
TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM	0.0013985999999999998	0.6353025094694414
SPONDYLOOCULAR SYNDROME; SOS	0.0013985999999999998	0.6353025094694414
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.0013985999999999998	0.6353025094694414
TRICHOHEPATOENTERIC SYNDROME 1	0.0013985999999999998	0.6353025094694414
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.0013985999999999998	0.6353025094694414
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.0013985999999999998	0.6353025094694414
ULBRIGHT-HODES SYNDROME	0.0013985999999999998	0.6353025094694414
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.0013985999999999998	0.6353025094694414
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.0013985999999999998	0.6353025094694414
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.0013985999999999998	0.6353025094694414
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.0013985999999999998	0.6353025094694414
CEREBROOCULONASAL SYNDROME	0.0013985999999999998	0.6353025094694414
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.0013985999999999998	0.6353025094694414
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.0013985999999999998	0.6353025094694414
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.0013985999999999998	0.6353025094694414
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.0013985999999999998	0.6353025094694414
PFEIFFER SYNDROME TYPE 3	0.0013985999999999998	0.6353025094694414
FIBROCHONDROGENESIS 1; FBCG1	0.0013985999999999998	0.6353025094694414
KAPUR-TORIELLO SYNDROME	0.0013985999999999998	0.6353025094694414
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.0013985999999999998	0.6353025094694414
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.0013985999999999998	0.6353025094694414
BARTSOCAS-PAPAS SYNDROME; BPS	0.0013985999999999998	0.6353025094694414
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.0013985999999999998	0.6353025094694414
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.0013985999999999998	0.6353025094694414
OROFACIODIGITAL SYNDROME TYPE 3	0.0013985999999999998	0.6353025094694414
MATTHEW-WOOD SYNDROME	0.0013985999999999998	0.6353025094694414
HALLERMANN-STREIFF SYNDROME; HSS	0.0013985999999999998	0.6353025094694414
AICA-RIBOSIDURIA	0.0013985999999999998	0.6353025094694414
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.0013985999999999998	0.6353025094694414
ROBERTS SYNDROME; RBS	0.0013985999999999998	0.6353025094694414
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0013985999999999998	0.6353025094694414
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.0013985999999999998	0.6353025094694414
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.0013985999999999998	0.6353025094694414
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.0013985999999999998	0.6353025094694414
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.0013985999999999998	0.6353025094694414
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.0013985999999999998	0.6353025094694414
ECTODERMAL DYSPLASIA SYNDROME	0.0013985999999999998	0.6353025094694414
GENITOPALATOCARDIAC SYNDROME	0.0013985999999999998	0.6353025094694414
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.0013985999999999998	0.6353025094694414
PFEIFFER SYNDROME TYPE 1	0.0013985999999999998	0.6353025094694414
6P22 MICRODELETION SYNDROME	0.0013985999999999998	0.6353025094694414
LOWRY-MACLEAN SYNDROME	0.0013985999999999998	0.6353025094694414
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.0013985999999999998	0.6353025094694414
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0013985999999999998	0.6353025094694414
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.0013985999999999998	0.6353025094694414
STROMME SYNDROME; STROMS	0.0013985999999999998	0.6353025094694414
FGFR2-RELATED BENT BONE DYSPLASIA	0.0013985999999999998	0.6353025094694414
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.0013985999999999998	0.6353025094694414
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.0013985999999999998	0.6353025094694414
COG5-CDG	0.0013985999999999998	0.6353025094694414
BENT BONE DYSPLASIA SYNDROME; BBDS	0.0013985999999999998	0.6353025094694414
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.0013985999999999998	0.6353025094694414
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0013985999999999998	0.6353025094694414
9P13 MICRODELETION SYNDROME	0.0013985999999999998	0.6353025094694414
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.0013985999999999998	0.6353025094694414
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.0013985999999999998	0.6353025094694414
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0013985999999999998	0.6353025094694414
ATELOSTEOGENESIS TYPE I	0.0013985999999999998	0.6353025094694414
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.0013985999999999998	0.6353025094694414
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.0013985999999999998	0.6353025094694414
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.0013985999999999998	0.6353025094694414
OROFACIODIGITAL SYNDROME IV; OFD4	0.0013985999999999998	0.6353025094694414
NEU-LAXOVA SYNDROME 2; NLS2	0.0013985999999999998	0.6353025094694414
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.0013985999999999998	0.6353025094694414
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.0013985999999999998	0.6353025094694414
BARBER-SAY SYNDROME; BBRSAY	0.0013985999999999998	0.6353025094694414
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.0013985999999999998	0.6353025094694414
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0013985999999999998	0.6353025094694414
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0013985999999999998	0.6353025094694414
DISTAL TRISOMY 5Q	0.0013985999999999998	0.6353025094694414
PHAVER SYNDROME	0.0013985999999999998	0.6353025094694414
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.0013985999999999998	0.6353025094694414
FOCAL DERMAL HYPOPLASIA; FDH	0.0013985999999999998	0.6353025094694414
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.0013985999999999998	0.6353025094694414
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0013985999999999998	0.6353025094694414
20P13 MICRODELETION SYNDROME	0.0013985999999999998	0.6353025094694414
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.0013985999999999998	0.6353025094694414
OTOONYCHOPERONEAL SYNDROME	0.0013985999999999998	0.6353025094694414
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.0013985999999999998	0.6353025094694414
ACROOSTEOLYSIS DOMINANT TYPE	0.0013985999999999998	0.6353025094694414
TRISOMY 13	0.0013985999999999998	0.6353025094694414
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.0013985999999999998	0.6353025094694414
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.0013985999999999998	0.6353025094694414
DDOST-CDG	0.0009615380000000001	0.43677070238111526
SPINOCEREBELLAR ATAXIA TYPE 1	0.0009615380000000001	0.43677070238111526
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.0009615380000000001	0.43677070238111526
SYDENHAM CHOREA	0.0009615380000000001	0.43677070238111526
SPINOCEREBELLAR ATAXIA TYPE 2	0.0009615380000000001	0.43677070238111526
MULTIMINICORE MYOPATHY	0.0009615380000000001	0.43677070238111526
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.0009615380000000001	0.43677070238111526
ROIFMAN SYNDROME	0.0009615380000000001	0.43677070238111526
SPINOCEREBELLAR ATAXIA TYPE 10	0.0009615380000000001	0.43677070238111526
7Q11.23 MICRODUPLICATION SYNDROME	0.0009615380000000001	0.43677070238111526
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0009615380000000001	0.43677070238111526
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0009615380000000001	0.43677070238111526
TEMPLE-BARAITSER SYNDROME	0.0009615380000000001	0.43677070238111526
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.0009615380000000001	0.43677070238111526
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.0009615380000000001	0.43677070238111526
MICROTRIPLICATION 11Q24.1	0.0009615380000000001	0.43677070238111526
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.0009615380000000001	0.43677070238111526
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0009615380000000001	0.43677070238111526
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.0009615380000000001	0.43677070238111526
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.0009615380000000001	0.43677070238111526
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.0009615380000000001	0.43677070238111526
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.0009615380000000001	0.43677070238111526
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.0009615380000000001	0.43677070238111526
ALG13-CDG	0.0009615380000000001	0.43677070238111526
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0009615380000000001	0.43677070238111526
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.0009615380000000001	0.43677070238111526
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.0009615380000000001	0.43677070238111526
GIANT AXONAL NEUROPATHY	0.0009615380000000001	0.43677070238111526
CLASSIC MULTIMINICORE MYOPATHY	0.0009615380000000001	0.43677070238111526
NEUTRAL LIPID STORAGE MYOPATHY	0.0009615380000000001	0.43677070238111526
COG1-CDG	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.0009615380000000001	0.43677070238111526
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0009615380000000001	0.43677070238111526
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.0009615380000000001	0.43677070238111526
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.0009615380000000001	0.43677070238111526
SUSAC SYNDROME	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0009615380000000001	0.43677070238111526
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.0009615380000000001	0.43677070238111526
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0009615380000000001	0.43677070238111526
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.0009615380000000001	0.43677070238111526
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.0009615380000000001	0.43677070238111526
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.0009615380000000001	0.43677070238111526
RAPID-ONSET DYSTONIA-PARKINSONISM	0.0009615380000000001	0.43677070238111526
ETHYLMALONIC ENCEPHALOPATHY	0.0009615380000000001	0.43677070238111526
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.0009615380000000001	0.43677070238111526
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.0009615380000000001	0.43677070238111526
SPINOCEREBELLAR ATAXIA TYPE 14	0.0009615380000000001	0.43677070238111526
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.0009615380000000001	0.43677070238111526
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0009615380000000001	0.43677070238111526
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.0009615380000000001	0.43677070238111526
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0009615380000000001	0.43677070238111526
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.0009615380000000001	0.43677070238111526
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0009615380000000001	0.43677070238111526
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0009615380000000001	0.43677070238111526
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, X-LINKED 19	0.0009615380000000001	0.43677070238111526
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.0009615380000000001	0.43677070238111526
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.0009615380000000001	0.43677070238111526
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, X-LINKED 93	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, X-LINKED 12; MRX12	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.0009615380000000001	0.43677070238111526
LESCH-NYHAN SYNDROME; LNS	0.0009615380000000001	0.43677070238111526
CHITAYAT SYNDROME	0.0009615380000000001	0.43677070238111526
ZUNICH NEUROECTODERMAL SYNDROME	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.0009615380000000001	0.43677070238111526
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.0009615380000000001	0.43677070238111526
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, X-LINKED 102	0.0009615380000000001	0.43677070238111526
SUDDEN CARDIAC FAILURE, INFANTILE	0.0009615380000000001	0.43677070238111526
BETHLEM MYOPATHY 2; BTHLM2	0.0009615380000000001	0.43677070238111526
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.0009615380000000001	0.43677070238111526
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.0009615380000000001	0.43677070238111526
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.0009615380000000001	0.43677070238111526
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.0009615380000000001	0.43677070238111526
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, X-LINKED 1	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.0009615380000000001	0.43677070238111526
MENKES DISEASE	0.0009615380000000001	0.43677070238111526
AICARDI SYNDROME; AIC	0.0009615380000000001	0.43677070238111526
COFFIN-LOWRY SYNDROME; CLS	0.0009615380000000001	0.43677070238111526
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.0009615380000000001	0.43677070238111526
SMITH-KINGSMORE SYNDROME; SKS	0.0009615380000000001	0.43677070238111526
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.0009615380000000001	0.43677070238111526
XYLOSIDASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.0009615380000000001	0.43677070238111526
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.0009615380000000001	0.43677070238111526
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0009615380000000001	0.43677070238111526
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.0009615380000000001	0.43677070238111526
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0009615380000000001	0.43677070238111526
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.0009615380000000001	0.43677070238111526
DESBUQUOIS DYSPLASIA 1	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.0009615380000000001	0.43677070238111526
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.0009615380000000001	0.43677070238111526
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.0009615380000000001	0.43677070238111526
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.0009615380000000001	0.43677070238111526
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.0009615380000000001	0.43677070238111526
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.0009615380000000001	0.43677070238111526
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.0009615380000000001	0.43677070238111526
TAY-SACHS DISEASE; TSD	0.0009615380000000001	0.43677070238111526
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.0009615380000000001	0.43677070238111526
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.0009615380000000001	0.43677070238111526
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0009615380000000001	0.43677070238111526
PSEUDO-TORCH SYNDROME 2	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0009615380000000001	0.43677070238111526
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.0009615380000000001	0.43677070238111526
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.0009615380000000001	0.43677070238111526
NEURAMINIDASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
GLYCOGEN STORAGE DISEASE IXB	0.0009615380000000001	0.43677070238111526
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.0009615380000000001	0.43677070238111526
OSTEOPENIA AND SPARSE HAIR	0.0009615380000000001	0.43677070238111526
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.0009615380000000001	0.43677070238111526
OPSISMODYSPLASIA; OPSMD	0.0009615380000000001	0.43677070238111526
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0009615380000000001	0.43677070238111526
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.0009615380000000001	0.43677070238111526
METACHROMATIC LEUKODYSTROPHY	0.0009615380000000001	0.43677070238111526
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.0009615380000000001	0.43677070238111526
COMBINED SAPOSIN DEFICIENCY	0.0009615380000000001	0.43677070238111526
LISSENCEPHALY 3; LIS3	0.0009615380000000001	0.43677070238111526
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0009615380000000001	0.43677070238111526
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.0009615380000000001	0.43677070238111526
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.0009615380000000001	0.43677070238111526
PITT-HOPKINS SYNDROME	0.0009615380000000001	0.43677070238111526
SOTOS SYNDROME 2	0.0009615380000000001	0.43677070238111526
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0009615380000000001	0.43677070238111526
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.0009615380000000001	0.43677070238111526
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.0009615380000000001	0.43677070238111526
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0009615380000000001	0.43677070238111526
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0009615380000000001	0.43677070238111526
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.0009615380000000001	0.43677070238111526
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.0009615380000000001	0.43677070238111526
LIVER FAILURE, INFANTILE, TRANSIENT	0.0009615380000000001	0.43677070238111526
EPILEPSY, HOT WATER, 1	0.0009615380000000001	0.43677070238111526
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.0009615380000000001	0.43677070238111526
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.0009615380000000001	0.43677070238111526
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.0009615380000000001	0.43677070238111526
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.0009615380000000001	0.43677070238111526
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.0009615380000000001	0.43677070238111526
PORPHYRIA, ACUTE HEPATIC	0.0009615380000000001	0.43677070238111526
EPISODIC ATAXIA, TYPE 6	0.0009615380000000001	0.43677070238111526
OSTEOGENESIS IMPERFECTA, TYPE X	0.0009615380000000001	0.43677070238111526
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.0009615380000000001	0.43677070238111526
NEMALINE MYOPATHY 7; NEM7	0.0009615380000000001	0.43677070238111526
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0009615380000000001	0.43677070238111526
TENORIO SYNDROME; TNORS	0.0009615380000000001	0.43677070238111526
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0009615380000000001	0.43677070238111526
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.0009615380000000001	0.43677070238111526
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0009615380000000001	0.43677070238111526
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.0009615380000000001	0.43677070238111526
GLYCINE ENCEPHALOPATHY; GCE	0.0009615380000000001	0.43677070238111526
SPINOCEREBELLAR ATAXIA 13	0.0009615380000000001	0.43677070238111526
MYOPATHY, CENTRONUCLEAR, 5	0.0009615380000000001	0.43677070238111526
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0009615380000000001	0.43677070238111526
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.0009615380000000001	0.43677070238111526
RIGID SPINE MUSCULAR DYSTROPHY 1	0.0009615380000000001	0.43677070238111526
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.0009615380000000001	0.43677070238111526
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.0009615380000000001	0.43677070238111526
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.0009615380000000001	0.43677070238111526
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.0009615380000000001	0.43677070238111526
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0009615380000000001	0.43677070238111526
PIERSON SYNDROME	0.0009615380000000001	0.43677070238111526
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.0009615380000000001	0.43677070238111526
JOUBERT SYNDROME 4	0.0009615380000000001	0.43677070238111526
PEROXISOME BIOGENESIS DISORDER 11B	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0009615380000000001	0.43677070238111526
KLEEFSTRA SYNDROME	0.0009615380000000001	0.43677070238111526
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.0009615380000000001	0.43677070238111526
JOUBERT SYNDROME 5	0.0009615380000000001	0.43677070238111526
LISSENCEPHALY 5; LIS5	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.0009615380000000001	0.43677070238111526
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0009615380000000001	0.43677070238111526
NEMALINE MYOPATHY 4	0.0009615380000000001	0.43677070238111526
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.0009615380000000001	0.43677070238111526
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.0009615380000000001	0.43677070238111526
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.0009615380000000001	0.43677070238111526
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.0009615380000000001	0.43677070238111526
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.0009615380000000001	0.43677070238111526
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.0009615380000000001	0.43677070238111526
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0009615380000000001	0.43677070238111526
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.0009615380000000001	0.43677070238111526
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.0009615380000000001	0.43677070238111526
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.0009615380000000001	0.43677070238111526
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0009615380000000001	0.43677070238111526
ADDUCTED THUMBS SYNDROME	0.0009615380000000001	0.43677070238111526
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0009615380000000001	0.43677070238111526
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.0009615380000000001	0.43677070238111526
CHIARI MALFORMATION TYPE II	0.0009615380000000001	0.43677070238111526
HYPERCALCEMIA, INFANTILE, 1	0.0009615380000000001	0.43677070238111526
ASPARTYLGLUCOSAMINURIA; AGU	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0009615380000000001	0.43677070238111526
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.0009615380000000001	0.43677070238111526
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0009615380000000001	0.43677070238111526
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.0009615380000000001	0.43677070238111526
ZIMMERMANN-LABAND SYNDROME 1	0.0009615380000000001	0.43677070238111526
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0009615380000000001	0.43677070238111526
CAP MYOPATHY	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.0009615380000000001	0.43677070238111526
COHEN SYNDROME	0.0009615380000000001	0.43677070238111526
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0009615380000000001	0.43677070238111526
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0009615380000000001	0.43677070238111526
GLYCOGEN STORAGE DISEASE IV	0.0009615380000000001	0.43677070238111526
GLYCOGEN STORAGE DISEASE II	0.0009615380000000001	0.43677070238111526
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0009615380000000001	0.43677070238111526
ETHANOLAMINOSIS	0.0009615380000000001	0.43677070238111526
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0009615380000000001	0.43677070238111526
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.0009615380000000001	0.43677070238111526
SPINOCEREBELLAR ATAXIA 2; SCA2	0.0009615380000000001	0.43677070238111526
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0009615380000000001	0.43677070238111526
SHPRINTZEN OMPHALOCELE SYNDROME	0.0009615380000000001	0.43677070238111526
VISCERAL STEATOSIS, CONGENITAL	0.0009615380000000001	0.43677070238111526
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0009615380000000001	0.43677070238111526
HUNTINGTON DISEASE-LIKE 1	0.0009615380000000001	0.43677070238111526
EHLERS-DANLOS SYNDROME, TYPE VI	0.0009615380000000001	0.43677070238111526
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0009615380000000001	0.43677070238111526
ACID PHOSPHATASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0009615380000000001	0.43677070238111526
SPINOCEREBELLAR ATAXIA 1	0.0009615380000000001	0.43677070238111526
MYOTONIC DYSTROPHY 1	0.0009615380000000001	0.43677070238111526
GLUTARIC ACIDEMIA I; GA1	0.0009615380000000001	0.43677070238111526
DYSTONIA 11, MYOCLONIC	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.0009615380000000001	0.43677070238111526
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.0009615380000000001	0.43677070238111526
CEREBELLAR HYPOPLASIA	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.0009615380000000001	0.43677070238111526
MAPLE SYRUP URINE DISEASE; MSUD	0.0009615380000000001	0.43677070238111526
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0009615380000000001	0.43677070238111526
JOHANSON-BLIZZARD SYNDROME; JBS	0.0009615380000000001	0.43677070238111526
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0009615380000000001	0.43677070238111526
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0009615380000000001	0.43677070238111526
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.0009615380000000001	0.43677070238111526
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.0009615380000000001	0.43677070238111526
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.0009615380000000001	0.43677070238111526
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.0009615380000000001	0.43677070238111526
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.0009615380000000001	0.43677070238111526
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.0009615380000000001	0.43677070238111526
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0009615380000000001	0.43677070238111526
HYPOPHOSPHATASIA, INFANTILE	0.0009615380000000001	0.43677070238111526
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.0009615380000000001	0.43677070238111526
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.0009615380000000001	0.43677070238111526
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.0009615380000000001	0.43677070238111526
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.0009615380000000001	0.43677070238111526
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000545554	0.2478134028679334
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.2478134028679334
AUSTRALIA ANTIGEN	0.000545554	0.2478134028679334
BARDET-BIEDL SYNDROME 1; BBS1	0.000545554	0.2478134028679334
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.2478134028679334
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.2478134028679334
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.2478134028679334
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.2478134028679334
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.2478134028679334
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.2478134028679334
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.000545554	0.2478134028679334
THYROID HYPOPLASIA	0.000545554	0.2478134028679334
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.000545554	0.2478134028679334
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.2478134028679334
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.000545554	0.2478134028679334
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.000545554	0.2478134028679334
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.2478134028679334
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.2478134028679334
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.2478134028679334
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000545554	0.2478134028679334
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000545554	0.2478134028679334
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.000545554	0.2478134028679334
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.2478134028679334
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.2478134028679334
TRANSKETOLASE DEFICIENCY	0.000545554	0.2478134028679334
KRABBE DISEASE	0.000545554	0.2478134028679334
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.2478134028679334
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.2478134028679334
DISTAL MONOSOMY 19P13.3	0.000545554	0.2478134028679334
LISSENCEPHALY 1; LIS1	0.000545554	0.2478134028679334
PROPIONIC ACIDEMIA	0.000545554	0.2478134028679334
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.2478134028679334
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.2478134028679334
HURLER SYNDROME	0.000545554	0.2478134028679334
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.2478134028679334
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.2478134028679334
LIG4 SYNDROME	0.000545554	0.2478134028679334
PHACE ASSOCIATION	0.000545554	0.2478134028679334
16P13.2 MICRODELETION SYNDROME	0.000545554	0.2478134028679334
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.000545554	0.2478134028679334
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.2478134028679334
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000545554	0.2478134028679334
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.2478134028679334
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000545554	0.2478134028679334
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.2478134028679334
ARGININOSUCCINIC ACIDURIA	0.000545554	0.2478134028679334
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000545554	0.2478134028679334
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.000545554	0.2478134028679334
ALSTROM SYNDROME; ALMS	0.000545554	0.2478134028679334
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.2478134028679334
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.000545554	0.2478134028679334
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.000545554	0.2478134028679334
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.2478134028679334
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.2478134028679334
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.2478134028679334
MYOCLONIC EPILEPSY OF INFANCY	0.000545554	0.2478134028679334
PELGER-HUET ANOMALY; PHA	0.000545554	0.2478134028679334
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.2478134028679334
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.2478134028679334
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.2478134028679334
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.2478134028679334
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.2478134028679334
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.2478134028679334
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.2478134028679334
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.000545554	0.2478134028679334
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.2478134028679334
COG2-CDG	0.000545554	0.2478134028679334
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.2478134028679334
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000545554	0.2478134028679334
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.2478134028679334
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.2478134028679334
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.2478134028679334
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.2478134028679334
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.2478134028679334
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.2478134028679334
CONGENITAL HYPOTHYROIDISM	0.000545554	0.2478134028679334
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000545554	0.2478134028679334
48,XYYY SYNDROME	0.000545554	0.2478134028679334
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.2478134028679334
RIDDLE SYNDROME	0.000545554	0.2478134028679334
XQ28 (MECP2) DUPLICATION	0.000545554	0.2478134028679334
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.2478134028679334
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.2478134028679334
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.000545554	0.2478134028679334
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.2478134028679334
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000545554	0.2478134028679334
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.2478134028679334
15Q13.3 MICRODELETION SYNDROME	0.000545554	0.2478134028679334
12Q14 MICRODELETION SYNDROME	0.000545554	0.2478134028679334
8P23.1 DUPLICATION SYNDROME	0.000545554	0.2478134028679334
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.2478134028679334
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000545554	0.2478134028679334
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000545554	0.2478134028679334
DYSTONIA-APHONIA SYNDROME	0.000545554	0.2478134028679334
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.2478134028679334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000545554	0.2478134028679334
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000545554	0.2478134028679334
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000545554	0.2478134028679334
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.2478134028679334
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.2478134028679334
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000545554	0.2478134028679334
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.000545554	0.2478134028679334
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000545554	0.2478134028679334
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.2478134028679334
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.000545554	0.2478134028679334
CHROMOSOME 16P13.3 DELETION SYNDROME	0.000545554	0.2478134028679334
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.2478134028679334
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.2478134028679334
ZEBRA BODY MYOPATHY	0.000545554	0.2478134028679334
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.2478134028679334
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.2478134028679334
CURRARINO SYNDROME	0.000545554	0.2478134028679334
INCONTINENTIA PIGMENTI	0.000545554	0.2478134028679334
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.000545554	0.2478134028679334
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.2478134028679334
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.2478134028679334
SEPTOOPTIC DYSPLASIA	0.000545554	0.2478134028679334
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000545554	0.2478134028679334
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.000545554	0.2478134028679334
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.2478134028679334
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.2478134028679334
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000545554	0.2478134028679334
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.2478134028679334
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.2478134028679334
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.2478134028679334
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.2478134028679334
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.000545554	0.2478134028679334
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.000545554	0.2478134028679334
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.000545554	0.2478134028679334
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.2478134028679334
KBG SYNDROME	0.000545554	0.2478134028679334
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.2478134028679334
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.2478134028679334
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000545554	0.2478134028679334
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.2478134028679334
PALLISTER-HALL SYNDROME	0.000545554	0.2478134028679334
MAPLE SYRUP URINE DISEASE	0.000545554	0.2478134028679334
ATHYREOSIS	0.000545554	0.2478134028679334
PIERPONT SYNDROME	0.000545554	0.2478134028679334
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.000545554	0.2478134028679334
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.000545554	0.2478134028679334
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.000545554	0.2478134028679334
PMM2-CDG	0.000545554	0.2478134028679334
ALG6-CDG	0.000545554	0.2478134028679334
ALG3-CDG	0.000545554	0.2478134028679334
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.2478134028679334
HYDROXYKYNURENINURIA	0.000545554	0.2478134028679334
ALG1-CDG	0.000545554	0.2478134028679334
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.2478134028679334
GAUCHER DISEASE, TYPE II	0.000545554	0.2478134028679334
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.2478134028679334
HEREDITARY FOLATE MALABSORPTION	0.000545554	0.2478134028679334
REVESZ SYNDROME	0.000545554	0.2478134028679334
ARGININEMIA	0.000545554	0.2478134028679334
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.2478134028679334
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.2478134028679334
TETRASOMY X	0.000545554	0.2478134028679334
SCHIZENCEPHALY	0.000545554	0.2478134028679334
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000545554	0.2478134028679334
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000545554	0.2478134028679334
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.000545554	0.2478134028679334
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.000545554	0.2478134028679334
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.2478134028679334
300270 ADRENOMYODYSTROPHY	0.000545554	0.2478134028679334
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.000545554	0.2478134028679334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000545554	0.2478134028679334
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000545554	0.2478134028679334
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.2478134028679334
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000545554	0.2478134028679334
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.2478134028679334
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000545554	0.2478134028679334
WAARDENBURG-SHAH SYNDROME	0.000545554	0.2478134028679334
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.2478134028679334
HYDROXYKYNURENINURIA	0.000545554	0.2478134028679334
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.2478134028679334
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.2478134028679334
HARTNUP DISORDER	0.000545554	0.2478134028679334
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.2478134028679334
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.2478134028679334
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000545554	0.2478134028679334
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000545554	0.2478134028679334
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000545554	0.2478134028679334
LANDAU-KLEFFNER SYNDROME	0.000545554	0.2478134028679334
MACDERMOT-WINTER SYNDROME	0.000545554	0.2478134028679334
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.2478134028679334
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.2478134028679334
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.2478134028679334
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.2478134028679334
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000545554	0.2478134028679334
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.2478134028679334
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.2478134028679334
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000545554	0.2478134028679334
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000545554	0.2478134028679334
JAWAD SYNDROME	0.000545554	0.2478134028679334
FRIED SYNDROME	0.000545554	0.2478134028679334
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.2478134028679334
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.2478134028679334
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.000545554	0.2478134028679334
TREACHER-COLLINS SYNDROME	0.000545554	0.2478134028679334
DPAGT1-CDG	0.000545554	0.2478134028679334
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.000545554	0.2478134028679334
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000545554	0.2478134028679334
PELLAGRA-LIKE SYNDROME	0.000545554	0.2478134028679334
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.2478134028679334
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.2478134028679334
SMITH-MAGENIS SYNDROME	0.000545554	0.2478134028679334
FREE SIALIC ACID STORAGE DISEASE	0.000545554	0.2478134028679334
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.2478134028679334
OROTIC ACIDURIA	0.000545554	0.2478134028679334
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.2478134028679334
SYNDROMIC DIARRHEA	0.000545554	0.2478134028679334
TAY-SACHS DISEASE	0.000545554	0.2478134028679334
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.2478134028679334
LISSENCEPHALY 2; LIS2	0.000545554	0.2478134028679334
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.2478134028679334
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.2478134028679334
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.2478134028679334
NETHERTON SYNDROME; NETH	0.000545554	0.2478134028679334
KEUTEL SYNDROME	0.000545554	0.2478134028679334
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000545554	0.2478134028679334
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.2478134028679334
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.2478134028679334
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000545554	0.2478134028679334
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000545554	0.2478134028679334
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.2478134028679334
WAISMAN SYNDROME; WSMN	0.000545554	0.2478134028679334
MARINESCO-SJÃ–GREN SYNDROME	0.000545554	0.2478134028679334
CITRULLINEMIA, CLASSIC	0.000545554	0.2478134028679334
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000545554	0.2478134028679334
ATELOSTEOGENESIS TYPE III	0.000545554	0.2478134028679334
MENTAL RETARDATION, X-LINKED 9	0.000545554	0.2478134028679334
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.2478134028679334
MUCOPOLYSACCHARIDOSIS TYPE 2	0.000545554	0.2478134028679334
MULTIPLE SULFATASE DEFICIENCY	0.000545554	0.2478134028679334
INFANTILE REFSUM DISEASE	0.000545554	0.2478134028679334
15Q24 MICRODELETION SYNDROME	0.000545554	0.2478134028679334
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.000545554	0.2478134028679334
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.2478134028679334
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.2478134028679334
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.2478134028679334
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.2478134028679334
ALPHA-MANNOSIDOSIS	0.000545554	0.2478134028679334
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.2478134028679334
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.2478134028679334
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.2478134028679334
CRANIOPHARYNGIOMA	0.000545554	0.2478134028679334
WYBURN-MASON SYNDROME	0.000545554	0.2478134028679334
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.2478134028679334
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.000545554	0.2478134028679334
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.000545554	0.2478134028679334
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.2478134028679334
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.2478134028679334
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.2478134028679334
BAND HETEROTOPIA; BH	0.000545554	0.2478134028679334
LOWRY-MACLEAN SYNDROME	0.000545554	0.2478134028679334
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000545554	0.2478134028679334
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.2478134028679334
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.000545554	0.2478134028679334
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.2478134028679334
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000545554	0.2478134028679334
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.2478134028679334
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.2478134028679334
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.2478134028679334
THYROID ECTOPIA	0.000545554	0.2478134028679334
MEDULLOBLASTOMA	0.000545554	0.2478134028679334
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000545554	0.2478134028679334
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000545554	0.2478134028679334
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.2478134028679334
BARATELA-SCOTT SYNDROME	0.000545554	0.2478134028679334
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.2478134028679334
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000545554	0.2478134028679334
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.2478134028679334
MENTAL RETARDATION, X-LINKED 88	0.000545554	0.2478134028679334
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.2478134028679334
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.000545554	0.2478134028679334
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.2478134028679334
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.2478134028679334
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.2478134028679334
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000545554	0.2478134028679334
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.2478134028679334
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.2478134028679334
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000545554	0.2478134028679334
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.2478134028679334
PYRUVATE DEHYDROGENASE DEFICIENCY	0.000545554	0.2478134028679334
RABSON-MENDENHALL SYNDROME	0.000545554	0.2478134028679334
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.000545554	0.2478134028679334
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000545554	0.2478134028679334
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.000545554	0.2478134028679334
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000545554	0.2478134028679334
HURLER SYNDROME	0.000545554	0.2478134028679334
NETHERTON SYNDROME	0.000545554	0.2478134028679334
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.2478134028679334
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.2478134028679334
ALSTRÃ–M SYNDROME	0.000545554	0.2478134028679334
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.2478134028679334
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000545554	0.2478134028679334
NARP SYNDROME	0.000545554	0.2478134028679334
NIEMANN-PICK DISEASE TYPE C	0.000545554	0.2478134028679334
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.2478134028679334
LEBER CONGENITAL AMAUROSIS	0.000545554	0.2478134028679334
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000545554	0.2478134028679334
MENTAL RETARDATION, X-LINKED 103	0.000545554	0.2478134028679334
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.2478134028679334
CEDNIK SYNDROME	0.000545554	0.2478134028679334
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.2478134028679334
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000545554	0.2478134028679334
COWDEN SYNDROME	0.000545554	0.2478134028679334
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.000545554	0.2478134028679334
GABA-TRANSAMINASE DEFICIENCY	0.000545554	0.2478134028679334
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.2478134028679334
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000545554	0.2478134028679334
CHROMOSOME 1P35 DELETION SYNDROME	0.000545554	0.2478134028679334
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.000545554	0.2478134028679334
MIETENS SYNDROME	0.000545554	0.2478134028679334
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.000545554	0.2478134028679334
N SYNDROME	0.000545554	0.2478134028679334
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000545554	0.2478134028679334
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000545554	0.2478134028679334
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.2478134028679334
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.2478134028679334
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000545554	0.2478134028679334
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000545554	0.2478134028679334
DISTAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.2478134028679334
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.2478134028679334
17Q12 MICRODELETION SYNDROME	0.000545554	0.2478134028679334
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.2478134028679334
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.2478134028679334
20P12.3 MICRODELETION SYNDROME	0.000545554	0.2478134028679334
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.2478134028679334
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.2478134028679334
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000545554	0.2478134028679334
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000545554	0.2478134028679334
HYPEREKPLEXIA 4; HKPX4	0.000545554	0.2478134028679334
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000545554	0.2478134028679334
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.2478134028679334
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.2478134028679334
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.2478134028679334
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000545554	0.2478134028679334
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.000545554	0.2478134028679334
1Q21.1 MICRODELETION SYNDROME	0.000545554	0.2478134028679334
1Q21.1 MICRODUPLICATION SYNDROME	0.000545554	0.2478134028679334
MICRO SYNDROME	0.000545554	0.2478134028679334
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.2478134028679334
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.2478134028679334
6Q25 MICRODELETION SYNDROME	0.000545554	0.2478134028679334
BAKER-GORDON SYNDROME; BAGOS	0.000545554	0.2478134028679334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.2478134028679334
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.2478134028679334
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000545554	0.2478134028679334
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000545554	0.2478134028679334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000545554	0.2478134028679334
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000545554	0.2478134028679334
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.2478134028679334
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000545554	0.2478134028679334
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.2478134028679334
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.2478134028679334
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000545554	0.2478134028679334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.2478134028679334
ROIFMAN-CHITAYAT SYNDROME	0.000545554	0.2478134028679334
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.000545554	0.2478134028679334
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000545554	0.2478134028679334
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.2478134028679334
L1 SYNDROME	0.000545554	0.2478134028679334
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.2478134028679334
LISSENCEPHALY 8; LIS8	0.000545554	0.2478134028679334
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.2478134028679334
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000545554	0.2478134028679334
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.000545554	0.2478134028679334
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000545554	0.2478134028679334
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.000545554	0.2478134028679334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000545554	0.2478134028679334
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.2478134028679334
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.2478134028679334
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.2478134028679334
POTOCKI-SHAFFER SYNDROME	0.000545554	0.2478134028679334
OTOFACIOCERVICAL SYNDROME	0.000545554	0.2478134028679334
ALAZAMI-YUAN SYNDROME	0.000545554	0.2478134028679334
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.2478134028679334
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.2478134028679334
ALG11-CDG	0.000545554	0.2478134028679334
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.2478134028679334
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000545554	0.2478134028679334
W SYNDROME	0.000545554	0.2478134028679334
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.2478134028679334
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.2478134028679334
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000545554	0.2478134028679334
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.2478134028679334
KLEEFSTRA SYNDROME	0.000545554	0.2478134028679334
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000545554	0.2478134028679334
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.2478134028679334
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.2478134028679334
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.2478134028679334
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.2478134028679334
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.000545554	0.2478134028679334
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000545554	0.2478134028679334
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.2478134028679334
MECKEL SYNDROME 13; MKS13	0.000545554	0.2478134028679334
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000545554	0.2478134028679334
RAHMAN SYNDROME	0.000545554	0.2478134028679334
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000545554	0.2478134028679334
PEHO-LIKE SYNDROME; PEHOL	0.000545554	0.2478134028679334
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.2478134028679334
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.2478134028679334
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.2478134028679334
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.2478134028679334
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.2478134028679334
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000545554	0.2478134028679334
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.000545554	0.2478134028679334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.000545554	0.2478134028679334
CITRULLINEMIA TYPE II	0.000545554	0.2478134028679334
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.2478134028679334
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.2478134028679334
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.2478134028679334
DONNAI-BARROW SYNDROME	0.000545554	0.2478134028679334
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.2478134028679334
1P36 DELETION SYNDROME	0.000545554	0.2478134028679334
MONOSOMY 18Q	0.000545554	0.2478134028679334
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000545554	0.2478134028679334
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000545554	0.2478134028679334
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.2478134028679334
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.2478134028679334
HYDRANENCEPHALY	0.000545554	0.2478134028679334
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.2478134028679334
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.000545554	0.2478134028679334
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.2478134028679334
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000545554	0.2478134028679334
VICI SYNDROME	0.000545554	0.2478134028679334
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.2478134028679334
MATERNAL PHENYLKETONURIA	0.000545554	0.2478134028679334
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.2478134028679334
XQ21 MICRODELETION SYNDROME	0.000545554	0.2478134028679334
CANAVAN DISEASE	0.000545554	0.2478134028679334
17Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.2478134028679334
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.2478134028679334
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000545554	0.2478134028679334
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.2478134028679334
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000545554	0.2478134028679334
HERNÃNDEZ-AGUIRRE NEGRETE SYNDROME	0.000545554	0.2478134028679334
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000545554	0.2478134028679334
DISTAL MONOSOMY 9P	0.000545554	0.2478134028679334
DEXTROCARDIA	0.000545554	0.2478134028679334
FLOATING-HARBOR SYNDROME	0.000545554	0.2478134028679334
FOIX-CHAVANY-MARIE SYNDROME	0.000545554	0.2478134028679334
COLE-CARPENTER SYNDROME	0.000545554	0.2478134028679334
EAST SYNDROME	0.000545554	0.2478134028679334
OCCIPITAL HORN SYNDROME	0.000545554	0.2478134028679334
MYOCLONIC-ASTASTIC EPILEPSY	0.000545554	0.2478134028679334
EARLY MYOCLONIC ENCEPHALOPATHY	0.000545554	0.2478134028679334
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.000545554	0.2478134028679334
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.2478134028679334
COHEN SYNDROME	0.000545554	0.2478134028679334
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.2478134028679334
DYSKERATOSIS CONGENITA	0.000545554	0.2478134028679334
GERMAN SYNDROME	0.000545554	0.2478134028679334
GERODERMA OSTEODYSPLASTICA	0.000545554	0.2478134028679334
TRISOMY 8Q	0.000545554	0.2478134028679334
DISTAL TRISOMY 18Q	0.000545554	0.2478134028679334
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000545554	0.2478134028679334
17P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.2478134028679334
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.000545554	0.2478134028679334
BRAIN-LUNG-THYROID SYNDROME	0.000545554	0.2478134028679334
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000545554	0.2478134028679334
HARTNUP DISEASE	0.000545554	0.2478134028679334
CHÃ‰DIAK-HIGASHI SYNDROME	0.000545554	0.2478134028679334
NEPHROGENIC DIABETES INSIPIDUS	0.000545554	0.2478134028679334
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.2478134028679334
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.2478134028679334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.000545554	0.2478134028679334
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.2478134028679334
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.000545554	0.2478134028679334
KBG SYNDROME	0.000545554	0.2478134028679334
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.2478134028679334
TRISOMY 9P	0.000545554	0.2478134028679334
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.2478134028679334
15Q11Q13 MICRODUPLICATION SYNDROME	0.000545554	0.2478134028679334
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.2478134028679334
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.2478134028679334
1Q44 MICRODELETION SYNDROME	0.000545554	0.2478134028679334
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.2478134028679334
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000545554	0.2478134028679334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000545554	0.2478134028679334
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000545554	0.2478134028679334
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.2478134028679334
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.2478134028679334
RFT1-CDG	0.000545554	0.2478134028679334
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.2478134028679334
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.2478134028679334
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.2478134028679334
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000545554	0.2478134028679334
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.2478134028679334
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.2478134028679334
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.2478134028679334
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.2478134028679334
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.2478134028679334
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.2478134028679334
CONGENITAL DISORDER OF GLYCOSYLATION	0.000545554	0.2478134028679334
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.2478134028679334
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.2478134028679334
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.2478134028679334
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.2478134028679334
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.2478134028679334
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.2478134028679334
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.2478134028679334
PENTASOMY X	0.000545554	0.2478134028679334
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.2478134028679334
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.2478134028679334
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.000545554	0.2478134028679334
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.000545554	0.2478134028679334
TRANSALDOLASE DEFICIENCY	0.000545554	0.2478134028679334
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.2478134028679334
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.2478134028679334
2Q37 MICRODELETION SYNDROME	0.000545554	0.2478134028679334
MICROVILLUS INCLUSION DISEASE	0.000545554	0.2478134028679334
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000545554	0.2478134028679334
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.2478134028679334
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000545554	0.2478134028679334
USHER SYNDROME TYPE 1	0.000545554	0.2478134028679334
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.000545554	0.2478134028679334
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.2478134028679334
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.000545554	0.2478134028679334
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000545554	0.2478134028679334
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.2478134028679334
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.2478134028679334
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.2478134028679334
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000545554	0.2478134028679334
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000545554	0.2478134028679334
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.2478134028679334
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.2478134028679334
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.2478134028679334
STEEL SYNDROME; STLS	0.000545554	0.2478134028679334
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.2478134028679334
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.2478134028679334
WEAVER SYNDROME	0.000545554	0.2478134028679334
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.2478134028679334
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.2478134028679334
WILSON-TURNER SYNDROME	0.000545554	0.2478134028679334
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.2478134028679334
FUCOSIDOSIS	0.000545554	0.2478134028679334
PROPIONIC ACIDEMIA	0.000545554	0.2478134028679334
ISOLATED PLAGIOCEPHALY	0.000545554	0.2478134028679334
EPIDERMAL NEVUS SYNDROME	0.000545554	0.2478134028679334
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.2478134028679334
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.2478134028679334
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.2478134028679334
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.000545554	0.2478134028679334
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.000545554	0.2478134028679334
TRISOMY X	0.000545554	0.2478134028679334
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.2478134028679334
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.2478134028679334
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.2478134028679334
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.2478134028679334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.2478134028679334
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000545554	0.2478134028679334
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.2478134028679334
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.2478134028679334
ABETAL34V AMYLOIDOSIS	0.000545554	0.2478134028679334
SRD5A3-CDG	0.000545554	0.2478134028679334
FILIPPI SYNDROME	0.000545554	0.2478134028679334
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.2478134028679334
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000545554	0.2478134028679334
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.2478134028679334
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000545554	0.2478134028679334
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000545554	0.2478134028679334
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.000545554	0.2478134028679334
ISOVALERIC ACIDEMIA	0.000545554	0.2478134028679334
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.2478134028679334
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000545554	0.2478134028679334
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.2478134028679334
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.2478134028679334
FARBER DISEASE	0.000545554	0.2478134028679334
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.2478134028679334
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000545554	0.2478134028679334
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.000545554	0.2478134028679334
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.2478134028679334
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.2478134028679334
LISSENCEPHALY 4	0.000545554	0.2478134028679334
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.000545554	0.2478134028679334
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.2478134028679334
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.2478134028679334
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.000545554	0.2478134028679334
SIMPSON-GOLABI-BEHMEL SYNDROME	0.000545554	0.2478134028679334
GRISCELLI SYNDROME	0.000545554	0.2478134028679334
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.2478134028679334
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000545554	0.2478134028679334
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.000545554	0.2478134028679334
HSD10 DISEASE	0.000545554	0.2478134028679334
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.2478134028679334
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.000545554	0.2478134028679334
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.2478134028679334
CHROMOSOME 19P13.13 DELETION SYNDROME	0.000545554	0.2478134028679334
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.000545554	0.2478134028679334
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.2478134028679334
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.2478134028679334
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.2478134028679334
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.2478134028679334
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.2478134028679334
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.2478134028679334
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.2478134028679334
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.2478134028679334
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.2478134028679334
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.2478134028679334
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.2478134028679334
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.2478134028679334
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.2478134028679334
SLC35A2-CDG	0.000545554	0.2478134028679334
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000545554	0.2478134028679334
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000545554	0.2478134028679334
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.000545554	0.2478134028679334
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.2478134028679334
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.2478134028679334
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.2478134028679334
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.2478134028679334
HOLOPROSENCEPHALY 11	0.000545554	0.2478134028679334
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000545554	0.2478134028679334
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.2478134028679334
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.000545554	0.2478134028679334
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.2478134028679334
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.2478134028679334
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000545554	0.2478134028679334
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.2478134028679334
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000545554	0.2478134028679334
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000545554	0.2478134028679334
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000545554	0.2478134028679334
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.2478134028679334
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000545554	0.2478134028679334
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000545554	0.2478134028679334
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.2478134028679334
CONGENITAL VARICELLA SYNDROME	0.000545554	0.2478134028679334
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.2478134028679334
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.2478134028679334
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.000545554	0.2478134028679334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.000545554	0.2478134028679334
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.2478134028679334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.2478134028679334
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.2478134028679334
1P21.3 MICRODELETION SYNDROME	0.000545554	0.2478134028679334
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.2478134028679334
SENIOR-LOKEN SYNDROME 9	0.000545554	0.2478134028679334
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.000545554	0.2478134028679334
SECKEL SYNDROME 8; SCKL8	0.000545554	0.2478134028679334
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.2478134028679334
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.000545554	0.2478134028679334
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.2478134028679334
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.2478134028679334
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.2478134028679334
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000545554	0.2478134028679334
HEREDITARY OROTIC ACIDURIA	0.000545554	0.2478134028679334
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000545554	0.2478134028679334
11P15.4 MICRODUPLICATION SYNDROME	0.000545554	0.2478134028679334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000545554	0.2478134028679334
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000545554	0.2478134028679334
MEVALONIC ACIDURIA	0.000545554	0.2478134028679334
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.2478134028679334
MEIER-GORLIN SYNDROME 7	0.000545554	0.2478134028679334
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.2478134028679334
PEHO SYNDROME	0.000545554	0.2478134028679334
MIRAGE SYNDROME; MIRAGE	0.000545554	0.2478134028679334
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.000545554	0.2478134028679334
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.2478134028679334
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000545554	0.2478134028679334
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.2478134028679334
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.2478134028679334
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.2478134028679334
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.2478134028679334
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000545554	0.2478134028679334
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.2478134028679334
EVEN-PLUS SYNDROME	0.000545554	0.2478134028679334
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.2478134028679334
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.2478134028679334
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.2478134028679334
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.000545554	0.2478134028679334
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.2478134028679334
SECKEL SYNDROME 9; SCKL9	0.000545554	0.2478134028679334
PITT-HOPKINS SYNDROME	0.000545554	0.2478134028679334
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000545554	0.2478134028679334
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.000545554	0.2478134028679334
PYRIDOXINE-DEPENDENT EPILEPSY	0.000545554	0.2478134028679334
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.2478134028679334
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.2478134028679334
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.2478134028679334
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.000545554	0.2478134028679334
BARDET-BIEDL SYNDROME 2	0.000545554	0.2478134028679334
SEVERE CANAVAN DISEASE	0.000545554	0.2478134028679334
SENIOR-LOKEN SYNDROME	0.000545554	0.2478134028679334
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.000545554	0.2478134028679334
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.2478134028679334
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.2478134028679334
WEBB-DATTANI SYNDROME; WEDAS	0.000545554	0.2478134028679334
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.2478134028679334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.2478134028679334
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000545554	0.2478134028679334
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000545554	0.2478134028679334
CULLER-JONES SYNDROME; CJS	0.000545554	0.2478134028679334
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.2478134028679334
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.2478134028679334
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.2478134028679334
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.2478134028679334
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000545554	0.2478134028679334
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.2478134028679334
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.2478134028679334
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.2478134028679334
CHOPS SYNDROME; CHOPS	0.000545554	0.2478134028679334
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.2478134028679334
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.2478134028679334
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.2478134028679334
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.2478134028679334
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.2478134028679334
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.000545554	0.2478134028679334
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.2478134028679334
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000545554	0.2478134028679334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.2478134028679334
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.2478134028679334
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000545554	0.2478134028679334
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000545554	0.2478134028679334
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.2478134028679334
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.2478134028679334
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.2478134028679334
OXOGLUTARIC ACIDURIA	0.000545554	0.2478134028679334
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.2478134028679334
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000545554	0.2478134028679334
SARCOSINEMIA	0.000545554	0.2478134028679334
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.2478134028679334
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.2478134028679334
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.000545554	0.2478134028679334
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.2478134028679334
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.2478134028679334
SOTOS SYNDROME	0.000545554	0.2478134028679334
